Surgical stapling apparatus including releasable surgical buttress

- COVIDIEN LP

A staple cartridge for use with a surgical stapling apparatus includes a cartridge body including a tissue contacting surface defining a plurality of staple retaining slots, a staple disposed within each staple retaining slot of the cartridge body, and a substantially circular buttress. The buttress includes an inner portion, an outer portion, and a middle portion extending between the inner portion and the outer portion. At least one stiffened region joins the buttress to the tissue contacting surface of the cartridge body. The inner portion, the middle portion, the outer portion, and the at least one stiffened region are all formed from a common material.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a Divisional Application which claims the benefit of and priority to U.S. patent application Ser. No. 15/168,924, filed on May 31, 2016, which is a Division Application which claims the benefit of and priority to U.S. patent application Ser. No. 13/325,481, filed on Dec. 14, 2011 (now U.S. Pat. No. 9,351,731), the entire disclosures of each of which is hereby incorporated by reference herein.

BACKGROUND Technical Field

The present disclosure relates to surgical stapling apparatus including surgical buttresses which are releasably attached to the surgical stapling apparatus, and in particular, to surgical stapling apparatus having surgical buttresses having at least a portion with increased rigidity and/or stability.

Background of Related Art

Surgical stapling apparatus are employed by surgeons to sequentially or simultaneously apply one or more rows of fasteners, e.g., staples or two-part fasteners, to body tissue for the purpose of joining segments of body tissue together. Such apparatus generally include a pair of jaws or finger-like structures between which the body tissue to be joined is placed. When the stapling apparatus is actuated, or “fired”, longitudinally moving firing bars contact staple drive members in one of the jaws. The staple drive members push the surgical staples through the body tissue and into an anvil in the opposite jaw which forms the staples. If tissue is to be removed or separated, a knife blade can be provided in the jaws of the apparatus to cut the tissue between the lines of staples.

A number of surgical stapling apparatus rely on secondary materials, such as adhesives or mounting structures (e.g., sutures) to maintain a surgical buttress on the stapling apparatus. The use of additional materials may leave a residue in the body after implantation and/or require increased firing forces as each material must be transected by the knife blade to detach the surgical buttress from the stapling apparatus.

It would be desirable to provide a buttress that may be releasably secured to a surgical stapling apparatus without the need for a secondary material or mounting structure.

Buttress materials that are formed from non-woven or mesh-like materials are known. These materials are relatively flexible and can shift on the surgical stapling apparatus. It may be desirable in at least certain applications to provide a buttress that has a stiffer construction or at least some stiffer portions to facilitate the placement of the buttress on the apparatus, or the placement of the buttress on tissue, or both.

SUMMARY

According to an aspect of the present disclosure, a staple cartridge for use with a surgical stapling apparatus includes a cartridge body including a tissue contacting surface defining a plurality of staple retaining slots, a staple disposed within each staple retaining slot of the cartridge body, and a substantially circular buttress. The buttress includes an inner portion, an outer portion, and a middle portion extending between the inner and outer portions. At least one stiffened region joins the buttress to the tissue contacting surface of the cartridge body. The inner portion, the middle portion, the outer portion, and the at least one stiffened region are all formed from a common material.

The stiffened region may be disposed in any portion of the buttress. In embodiments, at least the outer portion of the buttress includes the stiffened region. In embodiments, at least the inner portion of the buttress includes the stiffened region. In embodiments, the stiffened region includes a plurality of spokes extending radially outward from the inner portion of the buttress to the outer portion of the buttress. In some embodiments, the stiffened region may be disposed radially inward of the staple retaining slots. Alternatively, or additionally, the stiffened region may be disposed radially outward of the staple retaining slots.

The stiffened region may include ruffles. The ruffles may be folds, pleats, undulations, corrugations, creases, ridges, or bends. The stiffened region may be a localized crosslinked region of the buttress. The buttress may include a stiffening agent.

The buttress may include a flange. In embodiments, the outer portion of the buttress includes a terminal flange extending around an outer perimeter of the tissue contacting surface of the cartridge body. In such embodiments, the stiffened region may extend through the terminal flange. The terminal flange may be adjoined to an outer surface of the cartridge body.

The buttress material may include a central opening. The stiffened region may be concentric with the central opening. In embodiments, the inner portion of the buttress may include an interior flange annularly extending into the central opening. In such embodiments, the stiffened region may extend through the interior flange. The interior flange may be adjoined to an inner surface of the cartridge body.

Accordingly to another aspect of the present disclosure, a surgical stapling apparatus includes a tubular body portion, an anvil assembly, a cartridge body, a staple, and a substantially circular buttress. The tubular body portion of the surgical stapling apparatus has a distal end and a shaft with a connection portion, and the anvil assembly includes an anvil plate having staple forming recesses and a shaft connectable with the connection portion. The cartridge body is receivable in the distal end of the tubular body portion and includes a tissue contacting surface defining a plurality of staple retaining slots, the staple retaining slots defining at least two annular rows of staple retaining slots. A staple is disposed within each staple retaining slot of the cartridge body. The buttress includes an inner portion, an outer portion, and a middle portion extending between the inner portion and the outer portion. At least one stiffened region joins the buttress to the tissue contacting surface. The inner portion, the middle portion, the outer portion, and the at least one stiffened region are all formed from a common material.

Accordingly to yet another aspect of the present disclosure, a surgical stapling apparatus includes a tubular body portion, an anvil assembly, a cartridge body, a staple, and a substantially circular buttress. The tubular body portion of the surgical stapling apparatus has a distal end and a shaft with a connection portion, and the anvil assembly includes an anvil plate having staple forming recesses and a shaft connectable with the connection portion. The cartridge body is receivable in the distal end of the tubular body portion and includes a tissue contacting surface defining a plurality of staple retaining slots, the staple retaining slots defining at least two annular rows of staple retaining slots. A staple is disposed within each staple retaining slot of the cartridge body. The buttress includes at least one buttress region and at least one stiffened region formed from a common material.

The stiffened region may be disposed in any portion of the buttress. In embodiments, the stiffened region is disposed about an outer portion of the buttress. In embodiments, the stiffened region is disposed about an inner portion of the buttress. In embodiments, the stiffened region includes a plurality of spokes extending radially outward from an inner portion of the buttress to an outer portion of the buttress. In some embodiments, the stiffened region may be disposed radially inward of the staple retaining slots. Alternatively, or additionally, the stiffened region may be disposed radially outward of the staple retaining slots.

The stiffened region may include ruffles. The stiffened region may be a localized crosslinked region of the buttress. The buttress may include a stiffening agent.

The buttress may include a flange. In embodiments, the buttress includes a terminal flange extending around an outer perimeter of the tissue contacting surface of the cartridge body. In such embodiments, the stiffened region may extend through the terminal flange. The terminal flange may be adjoined to an outer surface of the cartridge body.

The buttress material may include a central opening. The stiffened region may be concentric with the central opening. In embodiments, the buttress may include an interior flange annularly extending into the central opening. In such embodiments, the stiffened region may extend through the interior flange. The interior flange may be adjoined to an inner surface of the cartridge body.

According to another aspect of the present disclosure, a surgical stapling apparatus includes a tubular body portion, an anvil assembly, a cartridge body, a staple, and a substantially circular buttress. The tubular body portion of the surgical stapling apparatus has a distal end and a shaft with a connection portion, and the anvil assembly includes an anvil plate having staple forming recesses and a shaft connectable with the connection portion. The cartridge body is receivable in the distal end of the tubular body portion and includes a tissue contacting surface defining a plurality of staple retaining slots, the staple retaining slots defining at least two annular rows of staple retaining slots. A staple is disposed within each staple retaining slot of the cartridge body. The buttress includes at least one buttress material and at least one stiffened region. The stiffened region is formed by adding a stiffening agent to the buttress material, the stiffening agent being a sugar, a salt, a starch, a hydrogel, a degradable polymer, or combinations thereof.

For example, sugars may include tahalose, sucrose, galatose, and glucose; salts may include sodium chloride, potassium chloride, and sodium phosphate; hydrogels may include degradable polyethylene glycol or poly(2-hydroxyethyl methacrylate); and degradable polymers may include poloxamers or polyhydroxy acids. In embodiments, the polyhydroxy acids are glycolide, lactide, trimethylene carbonate, p-dioxanone, ε-caprolactone, or combinations thereof. The stiffening agent may be coated on the buttress and/or impregnated therein.

BRIEF DESCRIPTION OF THE DRAWINGS

Embodiments of the presently disclosed surgical stapling apparatus and surgical buttress are described herein with reference to the accompanying drawings, wherein:

FIG. 1A is a perspective view of an illustrative embodiment of a surgical stapling apparatus and surgical buttress (shown separated from a staple cartridge assembly of the surgical stapling apparatus) in accordance with an embodiment of the present disclosure;

FIG. 1B is a cross-sectional view of a portion of the surgical stapling apparatus of FIG. 1A including a surgical buttress positioned within an intestinal area;

FIG. 1C is a top view of the surgical buttress depicted in FIG. 1B, illustrating its attachment to the surgical stapling apparatus of FIG. 1A;

FIGS. 2A-2D are top views of surgical buttresses in accordance with other embodiments of the present disclosure;

FIG. 2E is a perspective view of a surgical buttress in accordance with an embodiment of the present disclosure;

FIGS. 3A and 3B are cross-sectional views of a staple cartridge of the surgical stapling apparatus and a surgical buttress in accordance with an exemplary process of forming the stiffened regions in accordance with an embodiment of the present disclosure;

FIG. 4 is a schematic side view of a staple cartridge assembly and surgical buttress in accordance with an embodiment of the present disclosure;

FIG. 5A is a perspective view, with parts separated, of a staple cartridge assembly and surgical buttress in accordance with an embodiment of the present disclosure;

FIG. 5B is a schematic side view of the surgical buttress of FIG. 5A positioned on the staple cartridge assembly in accordance with an embodiment of the present disclosure;

FIG. 5C is a schematic perspective view of the surgical buttress of FIG. 5A positioned on the staple cartridge assembly in accordance with another embodiment of the present disclosure;

FIG. 6A is a perspective view, with parts separated, of a staple cartridge assembly and surgical buttress in accordance with an embodiment of the present disclosure;

FIG. 6B is a schematic side view of the surgical buttress of FIG. 6A positioned on the staple cartridge assembly in accordance with an embodiment of the present disclosure;

FIG. 6C is a schematic perspective view of the surgical buttress of FIG. 6A positioned on the staple cartridge assembly in accordance with another embodiment of the present disclosure;

FIGS. 7A-7C are top views of surgical buttresses, illustrating their attachment to the surgical stapling apparatus of FIG. 1A, in accordance with other embodiments of the present disclosure;

FIG. 8A is a perspective view of an illustrative embodiment of a surgical stapling apparatus in accordance with an embodiment of the present disclosure;

FIG. 8B is a perspective view, with parts separated, of the staple cartridge assembly of the surgical stapling apparatus and of the surgical buttress of FIG. 8A;

FIG. 9 is a perspective view of another illustrative embodiment of a surgical stapling apparatus for use with a surgical buttress of the present disclosure; and

FIG. 10 is a perspective view of yet another illustrative embodiment of a surgical stapling apparatus for use with a surgical buttress of the present disclosure.

 DETAILED DESCRIPTION OF THE EMBODIMENTS

Various exemplary embodiments of the present disclosure are discussed herein below in terms of surgical buttresses for use with surgical stapling apparatus. The surgical buttresses described herein may be used in joining the edges of wound tissue utilizing a surgical stapling apparatus which has at least one surgical buttress mounted thereon. The at least one surgical buttress is joined to the surgical stapling apparatus and includes at least one stiffened region. The at least one stiffened region can adhere, or otherwise be used to connect, the surgical buttress to the surgical stapling apparatus. In embodiments, actuation of a knife provides a force that impinges against the surgical buttress and displaces the buttress by a sufficient amount to weaken or break the bond created by the stiffened region between the surgical buttress and the surgical stapling apparatus, thereby releasing the surgical buttress therefrom before substantial cutting of the buttress material. In other embodiments, cutting of the surgical buttress by the knife blade releases a portion of the surgical buttress that is free of the stiffened region. Thus, the present disclosure describes surgical buttresses, surgical stapling apparatus supporting said surgical buttresses, and methods and mechanisms for using the same.

It should be understood that a variety of surgical stapling apparatus may be utilized with a surgical buttress of the present disclosure. For example, circular stapler configurations may be utilized, such as, for example those including end-to-end anastomosis staplers having a circular cartridge and anvil (see, e.g., commonly owned U.S. Pat. No. 5,915,616, entitled “Surgical Fastener Applying Apparatus,” the entire content of which is incorporated herein by this reference), and linear stapler configurations, such as, for example those including Duet TRS™ reloads and staplers with Tri-Staple™ technology, available through Covidien, which maintain a principal place of business at 555 Long Wharf Drive, North Haven, Conn. 06511, and transverse anastomosis staplers, such as, for example, EEA™ instruments, CEEA™ instruments, GIA™ instruments, EndoGIA™ instruments, and TA™ instruments, also available through Covidien. It should also be appreciated that the principles of the present disclosure are equally applicable to surgical staplers having alternate configurations, such as, for example, laparoscopic staplers (see, e.g., commonly owned U.S. Pat. Nos. 6,330,965 and 6,241,139, each entitled “Surgical Stapling Apparatus,” the entire contents of each of which being incorporated herein by this reference) and transverse anastomosis staplers (see, e.g., commonly owned U.S. Pat. Nos. 5,964,394 and 7,334,717, each entitled “Surgical Fastener Applying Apparatus”, the entire contents of each of which being incorporated herein by this reference).

Embodiments of the presently disclosed surgical buttress and surgical stapling apparatus will now be described in detail with reference to the drawing figures wherein like reference numerals identify similar or identical elements. In the following discussion, the terms “proximal” and “trailing” may be employed interchangeably, and should be understood as referring to the portion of a structure that is closer to a clinician during proper use. The terms “distal” and “leading” may also be employed interchangeably, and should be understood as referring to the portion of a structure that is further from the clinician during proper use. As used herein, the term “patient” should be understood as referring to a human subject or other animal, and the term “clinician” should be understood as referring to a doctor, nurse, or other care provider and may include support personnel.

Referring now to FIGS. 1A and 1B, there is disclosed an exemplary surgical stapling apparatus or surgical stapler 10 for use in stapling tissue and applying a buttress material or surgical buttress to the tissue. Surgical stapling apparatus 10 generally includes a handle assembly 12 having at least one pivotable actuating handle member 33, and an advancing member 35. Extending from handle member 12, there is provided a tubular body portion 14 which may be constructed so as to have a curved shape along its length. Body portion 14 terminates in a staple cartridge assembly 32 which includes an annular array of staple retaining slots 52 having a staple 50 disposed in each one of staple retaining slots 52. Positioned distally of staple cartridge assembly 32 there is provided an anvil assembly 20 including an anvil member 21 and a shaft 23 operatively associated therewith for removably connecting anvil assembly 20 to a distal end portion of stapling apparatus 10.

Staple cartridge assembly 32 may be fixedly connected to the distal end of tubular body portion 14 or may be configured to concentrically fit within the distal end of tubular body portion 14. Typically, staple cartridge assembly 32 includes a staple pusher 64 including a proximal portion having a generally frusto-conical shape and a distal portion defining two concentric rings of peripherally spaced fingers (not shown), each one of which is received within a respective staple retaining slot 52.

A knife 30, substantially in the form of an open cup with the rim thereof defining a knife blade 31, is disposed within staple cartridge assembly 32 and mounted to a distal surface of a staple pusher 64. The knife 30 is disposed radially inward of the annular arrays of staples 50. Accordingly, in use, as the staple pusher 64 is advanced, the knife 30 is also advanced axially outward.

Reference may be made to commonly owned U.S. Pat. No. 5,915,616 to Viola et al., referenced above, for a detailed discussion of the construction and operation of an annular stapling device, the disclosure of which is hereby incorporated by reference herein.

A surgical buttress 24 is releasably attached to the staple cartridge assembly 32 by at least one stiffened region 40 that bonds the surgical buttress 24 to a tissue contacting/facing surface of staple cartridge assembly 32. It should be understood that while the surgical buttress 24 is described herein as being associated with the staple cartridge assembly 32, the surgical buttress 24 may, alternatively or additionally, be associated with the anvil assembly 20. Surgical buttress 24 is provided to reinforce and seal staple lines applied to tissue by surgical stapling apparatus 10. Surgical buttress 24 may be configured into any shape, size, or dimension suitable to fit any surgical stapling, fastening, or firing apparatus.

Surgical buttress 24 is fabricated from a biocompatible material which is a bioabsorbable or non-absorbable, natural or synthetic material. It should of course be understood that any combination of natural, synthetic, bioabsorbable, and non-bioabsorbable materials may be used to form the surgical buttress. In embodiments, the entire surgical buttress 24, or portions thereof, may be fabricated from the same material, or combination of materials that is homogeneous throughout the surgical buttress 24. In other embodiments, the surgical buttress 24 may be formed of different materials.

The surgical buttress 24 may be porous, non-porous, or combinations thereof. It is also envisioned that surgical buttress 24 described herein may contain a plurality of layers in which any combination of non-porous and porous layers may be configured as discussed further below. For example, surgical buttress may be formed to include multiple non-porous layers and porous layers that are stacked in an alternating manner. In another example, surgical buttress may be formed in a “sandwich-like” manner wherein the outer layers of the surgical buttress include porous layers and the inner layers are non-porous layers. It is further envisioned that non-porous and porous layers may be positioned in any order relative to the tissue contacting surfaces of the staple cartridge/anvil assembly. Examples of multilayered surgical buttresses are disclosed in U.S. Patent Application Publication No. 2009/0001122 filed Jun. 27, 2007, entitled “Buttress and Surgical Stapling Apparatus,” the entire disclosure of which is incorporated by reference herein.

Some non-limiting examples of materials from which non-porous and/or porous layers of surgical buttress 24 may be made include, but are not limited to, poly(lactic acid), poly (glycolic acid), poly (hydroxybutyrate), poly (phosphazine), polyesters, polyethylene glycols, polyethylene oxides, polyacrylamides, polyhydroxyethylmethylacrylate, polyvinylpyrrolidone, polyvinyl alcohols, polyacrylic acid, polyacetate, polycaprolactone, polypropylene, aliphatic polyesters, glycerols, poly(amino acids), copoly (ether-esters), polyalkylene oxalates, polyamides, poly (iminocarbonates), polyalkylene oxalates, polyoxaesters, polyorthoesters, polyphosphazenes and copolymers, block copolymers, homopolymers, blends, and combinations thereof.

In embodiments, natural biological polymers are used in forming a non-porous layer of the surgical buttress. Suitable natural biological polymers include, but are not limited to, collagen, gelatin, fibrin, fibrinogen, elastin, keratin, albumin, hydroxyethyl cellulose, cellulose, oxidized cellulose, hydroxypropyl cellulose, carboxyethyl cellulose, carboxymethyl cellulose, chitan, chitosan, and combinations thereof. In addition, the natural biological polymers may be combined with any of the other polymeric materials described herein to produce a non-porous layer of the surgical buttress.

In embodiments, collagen of human and/or animal origin, e.g., type I porcine or bovine collagen, type I human collagen or type III human collagen, may be used to form a non-porous layer of the surgical buttress. In embodiments, a non-porous layer of the surgical buttress according to the present disclosure is made of collagen which is oxidized or a mixture in any proportions of non-oxidized and oxidized collagens.

The use of non-porous layer(s) in the surgical buttress may enhance the ability of the surgical buttress to resist tears and perforations during the manufacturing, shipping, handling, and stapling processes. Also, the use of a non-porous layer in the surgical buttress may also retard or prevent tissue ingrowth from surrounding tissues thereby acting as an adhesion barrier and preventing the formation of unwanted scar tissue. Thus, in embodiments, the non-porous layer(s) of the surgical buttress may possess anti-adhesion properties.

A non-porous layer of the surgical buttress may be formed using techniques within the purview of those skilled in the art, such as casting, molding, and the like.

Any of the porous layers of the surgical buttress may have openings or pores over at least a portion of a surface thereof. As described in more detail below, suitable materials for forming a porous layer include, but are not limited to, fibrous structures (e.g., knitted structures, woven structures, non-woven structures, etc.) and/or foams (e.g., open or closed cell foams). In embodiments, the pores may be in sufficient number and size so as to interconnect across the entire thickness of the porous layer. Woven fabrics, knitted fabrics, and open cell foam are illustrative examples of structures in which the pores can be in sufficient number and size so as to interconnect across the entire thickness of the porous layer. In embodiments, the pores may not interconnect across the entire thickness of the porous layer, but rather may be present at a portion thereof. Thus, in some embodiments, pores may be located on a portion of the porous layer, with other portions of the porous layer having a non-porous texture. Those skilled in the art reading the present disclosure will envision a variety of pore distribution patterns and configurations for the porous layer. Closed cell foam or fused non-woven materials are illustrative examples of structures in which the pores may not interconnect across the entire thickness of the porous layer.

Where a porous layer of the surgical buttress is fibrous, the fibers may be filaments or threads suitable for knitting or weaving or may be staple fibers, such as those frequently used for preparing non-woven materials. Suitable techniques for making fibrous structures are within the purview of those skilled in the art. The buttress material may be made using non-woven processes, including processes disclosed in U.S. patent application Ser. No. 13/293,215, filed Nov. 10, 2011, and entitled Hydrophilic Medical Devices, the disclosure of which is hereby incorporated by reference herein.

Where a porous layer of the surgical buttress is a foam, the porous layer may be formed using any method suitable to forming a foam or sponge including, but not limited to, the lyophilization or freeze-drying of a composition. Suitable techniques for making foams are within the purview of those skilled in the art.

The origin and types of collagens that may be used to form the porous layer are the same as those indicated above for the non-porous layer. However, the oxidized or non-oxidized collagen may be lyophilized, freeze-dried, or emulsified in the presence of a volume of air to create a foam and then freeze-dried, to form a porous compress.

In embodiments, a porous layer of the surgical buttress may be made from denatured collagen or collagen which has at least partially lost its helical structure through heating or any other method. The term “denatured collagen” means collagen which has lost its helical structure. The collagen used for the porous layer as described herein may be native collagen or atellocollagen. The collagen may have been previously chemically modified by oxidation, methylation, succinylation, ethylation, or any other known process.

The porous layer(s) may enhance the ability of the surgical buttress to absorb fluid, reduce bleeding, and seal the wound. Also, the porous layer(s) may allow for tissue ingrowth to fix the surgical buttress in place.

As illustrated in the current embodiment, and shown in FIGS. 1B and 1C, surgical buttress 24 includes a radially inner portion 42 defining an aperture 29 to receive shaft 23 of anvil assembly 20, a radially outer portion 46, and a radially middle portion 44 extending between the inner portion 42 and the outer portion 46. Stiffened region 40 is provided in at least a portion of the surgical buttress 24 and is configured to reduce shifting of the buttress or a portion of the buttress in relation to the staple retaining slots 52. The stiffened region 40 may be configured to releasably attach the surgical buttress 24 to the staple cartridge assembly 32.

For example, stiffened region 40 of surgical buttress 24 releasably attaches the staple cartridge assembly 32 in a manner which allows the surgical buttress 24 to be removed or released from the staple cartridge assembly 32 upon actuation of the knife 30. Accordingly, the stiffened region 40 is formed with a bond strength that is strong enough to hold the buttress 24 onto the staple cartridge assembly 32, but is weak enough to break free of the staple cartridge assembly 32 when the knife 30 impacts or penetrates the surgical buttress 24 to facilitate the release of the stiffened region 40 from the tissue contact surface 23 and thus, the surgical buttress 24 upon firing of surgical stapling apparatus 10.

As illustrated, stiffened region 40 is provided in the outer portion 46 of the surgical buttress 24 and bonds the surgical buttress 24 to the inwardly facing or tissue contacting surface 26 of the staple cartridge assembly 32. While the stiffened region 40 is shown as continuously extending around the outer portion 46 of the surgical buttress 24, it should be understood that stiffened region 40 may be discontinuous and include a plurality of stiffened regions 40a attaching the surgical buttress 24a to the surgical stapling apparatus 10, such as in the configuration illustrated in FIG. 2A, for example. In embodiments, the stiffened region 40, 40a may be disposed radially outward of the staple retaining slots 52 (FIGS. 1A and 1B).

Other configurations of the stiffened region 40 may be utilized to retain the surgical buttress 24 on the staple cartridge assembly 32. A stiffened region may be provided in other portions of a surgical buttress, such as, for example, in the inner portion as shown in FIG. 2B. The buttress shown in FIG. 2B can be part of any of the embodiments disclosed herein. In particular, FIG. 2B illustrates a stiffened region 40b extending continuously around an inner portion 42 of surgical buttress 24b. In other embodiments, a stiffened region 40c may be discontinuous as illustrated in FIG. 2C, for example. The buttress shown in FIG. 2C can be part of any of the embodiments disclosed herein. While stiffened region 40c is illustrated as a plurality of circular regions, stiffened region 40c may be formed of any number of suitably shaped and sized regions. In embodiments, the stiffened region 40b, 40c may be disposed radially inward of the staple retaining slots 52 (FIGS. 1A and 1B).

FIG. 2D illustrates a stiffened region 40d including a plurality of spokes extending radially outward from the inner portion 42 to the outer portion 46 of the surgical buttress 24d. The buttress shown in FIG. 2D can be part of any of the embodiments disclosed herein. While the spokes of the stiffened region 40d are illustrated as tapering from the inner portion 42 to the outer portion 46 of the surgical buttress 24, it should be understood that the spokes of the stiffened region 40d may taper from the outer portion 46 to the inner portion 42 of the surgical buttress 24, or be of uniform or changing width from the outer portion 46 to the inner portion 42.

FIG. 2E illustrates a surgical buttress 24e in which the stiffened region 40e extends throughout the inner, outer, and middle portions 42, 44, 46 thereof to form ruffles 41. The buttress shown in FIG. 2E can be part of any of the embodiments disclosed herein. In such embodiments, the ruffles 41 of the stiffened region 40e may be folds, pleats, undulations, corrugations, creases, ridges, bends, or include other fluctuations in the surface of the surgical buttress 24e to provide radial stability to the surgical buttress 24e relative to the staple cartridge assembly 32.

It is envisioned that other configurations, as well as combinations of the embodiments described above, may be utilized to form the stiffened region of a surgical buttress. For example, a surgical buttress may include a stiffened region in both the inner and outer portions of the surgical buttress, or may include ruffles in only a portion thereof. Other configurations will be readily apparent to those skilled in the art. It is envisioned that the number of stiffened regions, stiffened region size, positioning, and spacing can be varied to optimize the attachment of the surgical buttress to the surgical stapling apparatus, as well as to minimize the detachment force required during firing.

The stiffened regions may be formed by applying pressure and/or heat to compress the buttress, or a portion thereof. The pressure and heat may be used to join a surgical buttress to a surgical stapling apparatus, or may be applied during a manufacturing process prior to affixing of the surgical buttress to the surgical stapling apparatus. In embodiments, stiffened regions may be formed by melt pressing, heat staking, and the like. In embodiments in which a fibrous woven or non-woven buttress material is utilized, heat staking the fibers of the surgical buttress will cause the fibers to substantially coalesce or bond to create stiffened regions in the desired portions of the surgical buttress.

As illustrated in FIGS. 3A and 3B, a heat staking apparatus 1000, or the like, is illustrated for attaching a surgical buttress 24 to a staple cartridge assembly 32. The staple cartridge assembly 32 and surgical buttress 24 are placed within a retaining channel 1022 of base 1020 of heat staking apparatus 1000. Heat staking apparatus 1000 includes a compression device 1010 operably connected to a generator (not shown) for activating at least one heating element as is known in the art such that when a die plate 1012 contacts the surgical buttress 24 with a desired amount of pressure, a combination of the desired amount of pressure and/or thermal energy from the compression device 1010 joins the surgical buttress 24 to the staple cartridge assembly 32, forming stiffening region 40. Die 1012 may define a patterned surface 1014 including projections 1016 for forming individual stiffened regions 40 on the surgical buttress 24. Projections 1016 provide small contact surfaces so that the energy delivered by the compression device 1010 is concentrated over a small area. The projections are positioned to form stiffened region 40 and, as described above, may be any shape and size depending on the desired configuration.

In embodiments, the die plate 1012 may assume a concave shape so that the surgical buttress 24f, as shown in FIG. 4, may be heat pressed into a dome shape over staple cartridge assembly 32 to provide structural rigidity to the surgical buttress 24f.

In other embodiments, the stiffened regions may be formed by coating or impregnating the buttress material with a stiffening agent. The stiffening agent is biocompatible and may be dissolvable and/or degradable in vivo. Stiffening agents include, for example: sugars such as tehalose, sucrose, galatose, and glucose; salts such as sodium chloride, potassium chloride, and sodium phosphate; hydrogels such as degradable polyethylene glycol (PEG) or poly(2-hydroxyethyl methacrylate) (pHEMA); and degradable polymer coatings such as those including poloxamers as well as polyhydroxy acids prepared from lactone monomers such as glycolide, lactide, trimethylene carbonate, p-dioxanone, ε-caprolactone, and combinations thereof. In some embodiments, the degradable polymer coating may include a copolymer of glycolic acid and trimethylene carbonate. In embodiments, the degradable polymer coating may include a copolymer of 1-lactide and glycolide, and in some embodiments, the coating may include from about 70% 1-lactide and about 30% glycolide. In embodiments, the coating may include a copolymer of glycolide and e-caprolactone, and in some embodiments, from about 15% glycolide and about 85% e-caprolactone. The stiffening agent may impart rigidity to the surgical buttress for several minutes after contact with body fluids after insertion of the surgical stapling apparatus into the body cavity, leaving the buttress material supple after implantation.

Referring again to FIGS. 1A and 1B, surgical stapling apparatus 10 and detachable anvil assembly 20 are used in an anastomosis procedure to effect joining of intestinal sections 1 and 2. The anastomosis procedure is typically performed using minimally invasive surgical techniques including laparoscopic means and instrumentation. At the point in the procedure shown in FIG. 1B, a diseased intestinal section has been previously removed, anvil assembly 20 has been applied to the operative site either through a surgical incision or transanally and positioned within intestinal section 2, and tubular body portion 14 of surgical stapling apparatus 10 has been inserted transanally into intestinal section 1. Intestinal sections 1 and 2 are also shown temporarily secured about their respective components (e.g., shaft 23 of anvil assembly 20, and the distal end of tubular body portion 14) by conventional means such as a purse string suture “P”.

Thereafter, the clinician maneuvers anvil assembly 20 until the proximal end of shaft 23 is inserted into the distal end of tubular body portion 14 of surgical stapling apparatus 10, wherein a mounting structure within the distal end of tubular body portion 14 engages shaft 23 to effect the mounting. Anvil assembly 20 and tubular body portion 14 are then approximated to approximate intestinal sections 1, 2. Surgical stapling apparatus 10 is then fired. The staples 50 are fired, effecting stapling of intestinal sections 1, 2 to one another. The force of the knife 30 being fired breaks the bonds between the surgical buttress 24 and the staple cartridge assembly 32 created by stiffened region 40 thereby releasing the surgical buttress 24 from the staple cartridge assembly 32, and cutting the portion of tissue and surgical buttress 24 disposed radially inward of the knife 30, to complete the anastomosis.

Referring now to FIGS. 5A-6C, the surgical buttress may include an outer and/or inner flange. As shown in FIG. 5A-5C, surgical buttress 24 may include a terminal flange 21a extending around an outer perimeter of the tissue contacting surface 23 of the staple cartridge assembly 32. In embodiments, as shown in FIG. 5B, terminal flange 21a may be secured to a side surface 25a of the staple cartridge assembly 32. Terminal flange 21a of surgical buttress 24 may be joined to an outer side surface 25a of the staple cartridge assembly 32 via stiffened region 40 by melt pressing, heat staking, and the like, as described above. Alternatively, as shown in FIG. 5C, terminal flange 21a may extend outwardly from the staple cartridge assembly 32 such that the stiffened region 40, shown as ruffles 41a, provide stability around the edges of the staple cartridge assembly 32. The flange and/or ruffled portion disclosed herein can be included in any of the embodiments disclosed herein. Furthermore, the flange and/or the ruffled portion can be provided as a resilient material that resiliently engages the stapling apparatus or instrument. Furthermore, the flange and/or ruffled portion can be provided as a material having a desirable frictional characteristic for frictionally engaging the stapling apparatus or instrument.

As shown in FIG. 6A-6C, surgical buttress 24 may include an interior flange 21b annularly extending into aperture 29 of surgical buttress 24. In embodiments, as shown in FIG. 6B, interior flange 21b may be joined to an inner side surface 25b of the staple cartridge assembly 32 via stiffened region 40. Alternatively, as shown in FIG. 6C, internal flange 21b may extend inwardly into aperture 29 such that the stiffened region 40, shown as ruffles 41b, provide stability around the inner edges of the staple cartridge assembly 32. The interior flange and/or ruffled portion disclosed herein can be included in any of the embodiments disclosed herein. Furthermore, the flange and/or ruffled portion can be provided as a resilient material that resiliently engages the stapling apparatus or instrument. Furthermore, the flange and/or the ruffled portion can be provided as a material having a desirable frictional characteristic for frictionally engaging the stapling apparatus or instrument.

A surgical buttress of the present disclosure may include perforations or cut zones around and/or through the stiffened region to allow the surgical buttress to release by breaking the perforations or cut zones when a specified amount of force is applied thereto. Such perforations or cut zones can be included in any of the embodiments disclosed herein. Perforations or cut zones allow for repeatable separation of the surgical buttress from the staple cartridge and/or anvil assembly, and would allow for stronger attachment of a surgical buttress by the stiffened region while also reducing the risk of movement or detachment prior to firing of the surgical stapling apparatus. As detachment is effected by breaking the perforations, knife cutting of the surgical buttress is not required for buttress release and thus, increased firing forces may not be required.

Perforations may be formed by placing a surgical buttress between two knife blades with the spacing between the blades corresponding to a percentage of the average thickness of the surgical buttress. The knife blade spacing could be tailored in the range of about 10% to about 100% of the average thickness of the surgical buttress, in embodiments, from about 20% to about 90% of the average thickness, and in some embodiments, about 30% of the average thickness, to ensure that the surgical buttress is well secured during insertion but break away from the stiffened regions upon firing of the surgical stapling apparatus.

As illustrated in FIG. 7A, in one embodiment, a surgical buttress 24 includes at least one stiffened region 40 disposed radially outward of the annular row of staples 50 (FIG. 1B) and perforations 27 extending around the periphery of the stiffened regions 40. Upon firing the surgical stapling apparatus (FIGS. 1A and 1B), the knife 30 (FIG. 1B) disposed within the staple cartridge assembly 32 (FIG. 1B) will impact or penetrate the surgical buttress 24 and allow the portions of the surgical buttress 24 to separate from the stiffened regions 40, via perforations 27, and pull apart from the stiffened regions which are adhered to the staple cartridge assembly 32 (FIG. 1B).

In another embodiment, shown in FIG. 7B, a surgical buttress 24 includes at least one stiffened region 40 disposed radially inward of the annular row of staples 50 (FIG. 1B) and perforations 27 extending in a circumferential line through the stiffened regions 40. Upon firing the surgical stapling apparatus (FIGS. 1A and 1B), the knife 30 (FIG. 1B) disposed within the staple cartridge assembly 32 (FIG. 1B) will impact or penetrate the surgical buttress 24 separating a portion of the surgical buttress 24 extending radially outward of the perforations 27 from the portion of the surgical buttress 24.

It is envisioned that other configurations of perforations may be provided within a surgical buttress. For example, FIG. 7C illustrates a surgical buttress including at least one stiffened region 40a disposed radially inward of the annular row of staples 50 (shown in phantom) and at least one stiffened region 40b disposed radially outward of the annular row of staples 50. Perforations 27a and 27b are provided between stiffened regions 40a and 40b. In embodiments, the perforations 27a and 27b form a circumferential perforation line separating a middle portion 44 of the surgical buttress 24 from the inner and outer portions 42, 46, respectively, of the surgical buttress 24 such that the middle portion 44 can be stapled to tissue while the inner and outer portions 42, 46 remains with the staple cartridge assembly 32.

The surgical buttress of the present disclosure may be adapted for use with other surgical stapling apparatus in accordance with the present disclosure, such as the surgical stapling apparatus disclosed in commonly owned U.S. Pat. Nos. 6,330,965 and 6,241,139, the entire contents of which are incorporated by reference herein. For example, surgical stapling apparatus for both laparoscopic and/or endoscopic surgical procedures that include an elongated body and a tool assembly for applying a linear row or rows of staples can have a buttress as disclosed in any of the embodiments hereof. Apparatus for applying a linear row or rows of staples that are arranged for open surgical procedures can also have any of the buttresses disclosed in any of the embodiments discussed herein. Apparatus having a distal end adapted to releasably engage a disposable loading unit can be used, or apparatus having removable and replaceable cartridges can be used, with the surgical buttresses disclosed herein.

As illustrated in FIGS. 8A and 8B, an exemplary surgical stapling apparatus or surgical stapler 100 for use in stapling tissue and applying a buttress material or surgical buttress to the tissue. Surgical stapling apparatus 100 generally includes a handle 112 having an elongate tubular member 114 extending distally from handle 112. A jaw assembly 116 is mounted on a distal end 118 of elongate tubular member 114. Jaw assembly 116 includes a staple clinching anvil jaw member 120 and a receiving jaw member 122 configured to receive a staple cartridge assembly 132. Jaw assembly 116 may be permanently affixed to elongate tubular member 114 or may be detachable and thus replaceable with a new jaw assembly 116. Staple clinching anvil jaw member 120 is movably mounted on distal end 118 of jaw assembly 116 and is movable between an open position spaced apart from staple cartridge jaw member 122 to a closed position substantially adjacent staple cartridge jaw member 122.

Surgical stapling apparatus 100 further includes a trigger 133 movably mounted on handle 112. Actuation of trigger 133 initially operates to move anvil jaw member 120 from the open to the closed position relative to staple cartridge jaw member 122 and subsequently actuates surgical stapling apparatus 100 to apply lines of staples to tissue. In order to properly orient jaw assembly 116 relative to the tissue to be stapled, surgical stapling apparatus 100 is additionally provided with a rotation knob 134 mounted on handle 112. Rotation of rotation knob 134 relative to handle 112 rotates elongate tubular member 114 and jaw assembly 116 relative to handle 112 so as to properly orient jaw assembly 116 relative to the tissue to be stapled.

A driver 136 is provided to move anvil jaw member 120 between the open and closed positions relative to staple cartridge jaw member 122. Driver 136 moves between a longitudinal slot 138 formed in anvil jaw member 120. A knife (not shown) is associated with driver 136 to cut tissue captured between anvil jaw member 120 and staple cartridge jaw member 122 as driver 136 passes through slot 138.

As illustrated in the current embodiment and shown in FIG. 8B, the surgical buttress 124 is releasably attached to the staple cartridge assembly 132 and/or the anvil jaw member 120 by at least one stiffened region 140 that bonds the surgical buttress 124 to the inwardly facing or tissue contacting surface 126 of the staple cartridge 132 and/or the anvil jaw member 120, in a manner similar to the bonds securing surgical buttresses 24 to the staple cartridge assembly 32, as described above.

The surgical buttress of the present disclosure, in particular surgical buttress 124, may also be adapted for use with a surgical stapling apparatus, such as that shown and described in U.S. Pat. No. 7,334,717, entitled “Surgical Fastener Applying Apparatus,” the entire content of which is incorporated herein by reference. As illustrated in FIG. 9, surgical stapling apparatus 210 includes an anvil receiving section 220 and a cartridge receiving section 222. A surgical buttress (not shown) may be attached to at least one of an anvil 221 coupled to the anvil receiving section 220, a staple cartridge assembly 232 coupled to the cartridge receiving section 222, or both, as discussed above, by at least one stiffened region. The anvil receiving section 220 and the cartridge receiving section 222 are pivotally connected via handles 212, 213 for approximation during use. Following approximation of the anvil receiving section 220 and the cartridge receiving section 222, the surgical stapling apparatus 210 is fired by driving a firing slide 236 distally through the advancement of a firing lever 233. Distal movement of the firing slide 233 causes a plurality of cam bars to engage camming surfaces that interact with a plurality of pushers to expel a plurality of surgical staples (not shown) from the cartridge receiving section 222. The staples are positioned on either side of a track which guides a knife (not shown) during longitudinal movement. The force of the knife being fired breaks the bonds between the surgical buttress and the staple cartridge, for example, created by the stiffened region between the surgical buttress and the staple cartridge, thereby releasing the surgical buttress from the staple cartridge, and severs tissue along a cut-line.

The surgical buttress of the present disclosure, in particular surgical buttress 124, may also be adapted for use with a transverse surgical stapling apparatus 310, as illustrated in FIG. 10. An exemplary transverse surgical stapling apparatus is shown and described in U.S. Pat. No. 5,964,394, entitled “Surgical Fastener Applying Device,” the entire content of which is incorporated herein by reference. The surgical stapling apparatus 310 includes an approximation lever 333, a movable handle 312, an elongated portion 314 that extends distally from the handle 312, and an arm 322 that extends from a distal end 315 of the elongated portion 314. The surgical stapling apparatus 310 further includes an anvil 321 that is orthogonally affixed to the arm 322, and a cartridge receiver 320 that is operatively coupled to the distal end 315 of the elongated portion 314 for retention of a staple cartridge assembly 332. A surgical buttress (not shown) may be joined to at least one of the anvil 321, staple cartridge assembly 332, or both as discussed above, via a stiffened region.

In embodiments, at least one bioactive agent may be combined with a surgical buttress of the present disclosure. The at least one bioactive agent may be disposed on a surface of the surgical buttress and/or impregnated therein. In these embodiments, the surgical buttress can also serve as a vehicle for delivery of the bioactive agent. The term “bioactive agent”, as used herein, is used in its broadest sense and includes any substance or mixture of substances that have clinical use. Consequently, bioactive agents may or may not have pharmacological activity per se, e.g., a dye, or fragrance. Alternatively a bioactive agent could be any agent which provides a therapeutic or prophylactic effect, a compound that affects or participates in tissue growth, cell growth, cell differentiation, an anti-adhesive compound, a compound that may be able to invoke a biological action such as an immune response, or could play any other role in one or more biological processes. It is envisioned that the bioactive agent may be applied to the surgical buttress in any suitable form of matter, e.g., films, powders, liquids, gels and the like.

Examples of classes of bioactive agents which may be utilized in accordance with the present disclosure include anti-adhesives, antimicrobials, analgesics, antipyretics, anesthetics, antiepileptics, antihistamines, anti-inflammatories, cardiovascular drugs, diagnostic agents, sympathomimetics, cholinomimetics, antimuscarinics, antispasmodics, hormones, growth factors, muscle relaxants, adrenergic neuron blockers, antineoplastics, immunogenic agents, immunosuppressants, gastrointestinal drugs, diuretics, steroids, lipids, lipopolysaccharides, polysaccharides, and enzymes. It is also intended that combinations of bioactive agents may be used.

Other bioactive agents which may be included as a bioactive agent in the surgical buttress of the present disclosure include: local anesthetics; non-steroidal antifertility agents; parasympathomimetic agents; psychotherapeutic agents; tranquilizers; decongestants; sedative hypnotics; steroids; sulfonamides; sympathomimetic agents; vaccines; vitamins; antimalarials; anti-migraine agents; anti-parkinson agents such as L-dopa; anti-spasmodics; anticholinergic agents (e.g. oxybutynin); antitussives; bronchodilators; cardiovascular agents such as coronary vasodilators and nitroglycerin; alkaloids; analgesics; narcotics such as codeine, dihydrocodeinone, meperidine, morphine and the like; non-narcotics such as salicylates, aspirin, acetaminophen, d-propoxyphene and the like; opioid receptor antagonists, such as naltrexone and naloxone; anti-cancer agents; anti-convulsants; anti-emetics; antihistamines; anti-inflammatory agents such as hormonal agents, hydrocortisone, prednisolone, prednisone, non-hormonal agents, allopurinol, indomethacin, phenylbutazone and the like; prostaglandins and cytotoxic drugs; estrogens; antibacterials; antibiotics; anti-fungals; anti-viral s; anticoagulants; anticonvulsants; antidepressants; antihistamines; and immunological agents.

Other examples of suitable bioactive agents which may be included include viruses and cells, peptides, polypeptides and proteins, analogs, muteins, and active fragments thereof, such as immunoglobulins, antibodies, cytokines (e.g. lymphokines, monokines, chemokines), blood clotting factors, hemopoietic factors, interleukins (IL-2, IL-3, IL-4, IL-6), interferons (β-IFN, (α-IFN and γ-IFN), erythropoietin, nucleases, tumor necrosis factor, colony stimulating factors (e.g., GCSF, GM-CSF, MCSF), insulin, anti-tumor agents and tumor suppressors, blood proteins, gonadotropins (e.g., FSH, LH, CG, etc.), hormones and hormone analogs (e.g., growth hormone), vaccines (e.g., tumoral, bacterial and viral antigens); somatostatin; antigens; blood coagulation factors; growth factors (e.g., nerve growth factor, insulin-like growth factor); protein inhibitors, protein antagonists, and protein agonists; nucleic acids, such as antisense molecules, DNA and RNA; oligonucleotides; polynucleotides; and ribozymes.

In embodiments, a reinforcement member may be positioned within or over a surgical buttress. In embodiments utilizing a multilayered surgical buttress, one or more reinforcement members may be positioned between, within, or at an external surface of a layer of the surgical buttress as are disclosed, for example, in U.S. Patent Application Publication No. 2009/0001122, referenced above.

Persons skilled in the art will understand that the devices and methods specifically described herein and illustrated in the accompanying figures are non-limiting exemplary embodiments, and that the description, disclosure, and figures should be construed merely exemplary of particular embodiments. It is to be understood, therefore, that the present disclosure is not limited to the precise embodiments described, and that various other changes and modifications may be effected by one skilled in the art without departing from the scope or spirit of the disclosure. Additionally, it is envisioned that the elements and features illustrated or described in connection with one exemplary embodiment may be combined with the elements and features of another exemplary embodiment without departing from the scope of the present disclosure, and that such modifications and variations are also intended to be included within the scope of the present disclosure. Accordingly, the subject matter of the present disclosure is not to be limited by what has been particularly shown and described, except as indicated by the appended claims.

Claims

1. A surgical stapling apparatus, comprising:

an elongate tubular member having a distal end;
a jaw assembly mounted on the distal end of the elongate tubular member, the jaw assembly including an anvil jaw member having a tissue contacting surface defining a longitudinal slot therethrough and a staple cartridge jaw member having a tissue contacting surface defining a longitudinal slot therethrough; and
a surgical buttress including a buttress body having a first rigidity and a stiffened region defined in the buttress body having a second rigidity greater than the first rigidity, the stiffened region continuously extending across a width of the surgical buttress from a first longitudinal side to a second longitudinal side of the buttress body, the stiffened region disposed over and extending across the longitudinal slot of the anvil or staple cartridge jaw member and attached to the tissue contacting surface of the anvil or staple cartridge jaw member on opposed sides of the longitudinal slot to releasably secure the surgical buttress to the anvil or staple cartridge jaw member.

2. The surgical stapling apparatus according to claim 1, wherein the surgical buttress has a rectangular shape including the first and second longitudinal sides and proximal and distal end portions.

3. The surgical stapling apparatus according to claim 2, wherein the stiffened region is defined in the proximal end portion of the surgical buttress.

4. The surgical stapling apparatus according to claim 2, wherein the stiffened region is defined in the distal end portion of the surgical buttress.

5. The surgical stapling apparatus according to claim 2, wherein the stiffened region is a first stiffened region defined in the proximal end portion of the surgical buttress and the surgical buttress includes a second stiffened region defined in the distal end portion of the surgical buttress.

6. The surgical stapling apparatus according to claim 5, wherein each of the first and second stiffened regions extends across the width of the surgical buttress from the first longitudinal side to the second longitudinal side of the buttress body.

7. The surgical stapling apparatus according to claim 5, wherein each of the first and second stiffened regions extends transversely across the longitudinal slot defined in the tissue contacting surface of the anvil or staple cartridge jaw member.

8. The surgical stapling apparatus according to claim 5, wherein the first and second stiffened regions are respectively disposed proximal and distal to staple retaining slots defined in the tissue contacting surface of the staple cartridge jaw member.

9. The surgical stapling apparatus according to claim 1, wherein the stiffened region is a compressed region of the buttress body of the surgical buttress.

10. The surgical stapling apparatus according to claim 1, wherein the surgical buttress includes a stiffening agent in the stiffened region.

11. A staple cartridge assembly for use with a surgical stapling apparatus, the staple cartridge assembly comprising:

a cartridge body including a tissue contacting surface defining a plurality of staple retaining slots and a longitudinal slot; and
a surgical buttress including a buttress body having a first rigidity and a stiffened region defined in the buttress body having a second rigidity greater than the first rigidity, the stiffened region continuously extending across a width of the surgical buttress from a first longitudinal side to a second longitudinal side of the buttress body, the stiffened region disposed over and extending across the longitudinal slot of the cartridge body and attached to the tissue contacting surface of the cartridge body on opposed sides of the longitudinal slot to releasably secure the surgical buttress to the cartridge body.

12. The staple cartridge assembly according to claim 11, wherein the surgical buttress has a rectangular shape defined by the first and second longitudinal sides and proximal and distal end portions.

13. The staple cartridge assembly according to claim 12, wherein the stiffened region is defined in the proximal end portion of the surgical buttress.

14. The staple cartridge assembly according to claim 12, wherein the stiffened region is defined in the distal end portion of the surgical buttress.

15. The staple cartridge assembly according to claim 12, wherein the stiffened region is disposed proximal or distal to the staple retaining slots defined in the tissue contacting surface of the cartridge body.

Referenced Cited
U.S. Patent Documents
3054406 September 1962 Usher
3079606 March 1963 Bobrov et al.
3124136 March 1964 Usher
3364200 January 1968 Ashton et al.
3490675 January 1970 Green et al.
3499591 March 1970 Green
3797494 March 1974 Zaffaroni
3939068 February 17, 1976 Wendt et al.
3948666 April 6, 1976 Kitanishi et al.
3953566 April 27, 1976 Gore
4064062 December 20, 1977 Yurko
4166800 September 4, 1979 Fong
4282236 August 4, 1981 Broom
4347847 September 7, 1982 Usher
4354628 October 19, 1982 Green
4416698 November 22, 1983 McCorsley, III
4429695 February 7, 1984 Green
4452245 June 5, 1984 Usher
4473670 September 25, 1984 Kessidis
4605730 August 12, 1986 Shalaby et al.
4626253 December 2, 1986 Broadnax, Jr.
4655221 April 7, 1987 Devereux
4834090 May 30, 1989 Moore
4838884 June 13, 1989 Dumican et al.
4927640 May 22, 1990 Dahlinder et al.
4930674 June 5, 1990 Barak
5002551 March 26, 1991 Linsky et al.
5014899 May 14, 1991 Presty et al.
5024841 June 18, 1991 Chu et al.
5040715 August 20, 1991 Green et al.
5057334 October 15, 1991 Vail
5065929 November 19, 1991 Schulze et al.
5112496 May 12, 1992 Dhawan et al.
5162430 November 10, 1992 Rhee et al.
5205459 April 27, 1993 Brinkerhoff et al.
5263269 November 23, 1993 Tjarnlund
5263629 November 23, 1993 Trumbull
5281197 January 25, 1994 Arias et al.
5307976 May 3, 1994 Olson et al.
5312023 May 17, 1994 Green et al.
5314471 May 24, 1994 Brauker et al.
5318221 June 7, 1994 Green et al.
5324775 June 28, 1994 Rhee et al.
5326013 July 5, 1994 Green et al.
5332142 July 26, 1994 Robinson et al.
5344454 September 6, 1994 Clarke et al.
5392979 February 28, 1995 Green et al.
5397324 March 14, 1995 Carroll et al.
5405072 April 11, 1995 Zlock et al.
5410016 April 25, 1995 Hubbell et al.
5425745 June 20, 1995 Green et al.
5441193 August 15, 1995 Gravener
5441507 August 15, 1995 Wilk
5443198 August 22, 1995 Viola et al.
5468253 November 21, 1995 Bezwada et al.
5484913 January 16, 1996 Stilwell et al.
5503638 April 2, 1996 Cooper et al.
5514379 May 7, 1996 Weissleder et al.
5542594 August 6, 1996 McKean et al.
5543441 August 6, 1996 Rhee et al.
5549628 August 27, 1996 Cooper et al.
5550187 August 27, 1996 Rhee et al.
5575803 November 19, 1996 Cooper et al.
5645915 July 8, 1997 Kranzler et al.
5653756 August 5, 1997 Clarke et al.
5683809 November 4, 1997 Freeman et al.
5690675 November 25, 1997 Sawyer et al.
5702409 December 30, 1997 Raybum et al.
5713920 February 3, 1998 Bezwada et al.
5752965 May 19, 1998 Francis et al.
5752974 May 19, 1998 Rhee et al.
5762256 June 9, 1998 Mastri et al.
5766188 June 16, 1998 Igaki
5769892 June 23, 1998 Kingwell
5782396 July 21, 1998 Mastri et al.
5799857 September 1, 1998 Robertson et al.
5810855 September 22, 1998 Rayburn et al.
5814057 September 29, 1998 Oi et al.
5819350 October 13, 1998 Wang
5833695 November 10, 1998 Yoon
5843096 December 1, 1998 Igaki et al.
5871135 February 16, 1999 Williamson, IV et al.
5874500 February 23, 1999 Rhee et al.
5895412 April 20, 1999 Tucker
5895415 April 20, 1999 Chow et al.
5902312 May 11, 1999 Frater et al.
5908427 June 1, 1999 McKean et al.
5915616 June 29, 1999 Viola et al.
5931847 August 3, 1999 Bittner et al.
5957363 September 28, 1999 Heck
5964394 October 12, 1999 Robertson
5964774 October 12, 1999 McKean et al.
5997895 December 7, 1999 Narotam et al.
6019791 February 1, 2000 Wood
6030392 February 29, 2000 Dakov
6032849 March 7, 2000 Mastri et al.
6045560 April 4, 2000 McKean et al.
6063097 May 16, 2000 Oi et al.
6080169 June 27, 2000 Turtel
6093557 July 25, 2000 Pui et al.
6099551 August 8, 2000 Gabbay
6142933 November 7, 2000 Longo et al.
6149667 November 21, 2000 Hovland et al.
6152943 November 28, 2000 Sawhney
6155265 December 5, 2000 Hammerslag
6156677 December 5, 2000 Brown Reed et al.
6165201 December 26, 2000 Sawhney et al.
6179862 January 30, 2001 Sawhney
6210439 April 3, 2001 Firmin et al.
6214020 April 10, 2001 Mulhauser et al.
6241139 June 5, 2001 Milliman et al.
6258107 July 10, 2001 Balazs et al.
6267772 July 31, 2001 Mulhauser et al.
6270530 August 7, 2001 Eldridge et al.
6273897 August 14, 2001 Dalessandro
6280453 August 28, 2001 Kugel et al.
6299631 October 9, 2001 Shalaby
6309569 October 30, 2001 Farrar et al.
6312457 November 6, 2001 DiMatteo et al.
6312474 November 6, 2001 Francis et al.
6325810 December 4, 2001 Hamilton
6330965 December 18, 2001 Milliman et al.
6399362 June 4, 2002 Pui et al.
6436030 August 20, 2002 Rehil
6454780 September 24, 2002 Wallace
6461368 October 8, 2002 Fogarty et al.
6500777 December 31, 2002 Wiseman et al.
6503257 January 7, 2003 Grant et al.
6514283 February 4, 2003 DiMatteo et al.
6514534 February 4, 2003 Sawhney
6517566 February 11, 2003 Hovland et al.
6551356 April 22, 2003 Rousseau
6566406 May 20, 2003 Pathak et al.
6568398 May 27, 2003 Cohen
6590095 July 8, 2003 Schleicher et al.
6592597 July 15, 2003 Grant
6605294 August 12, 2003 Sawhney
6610006 August 26, 2003 Amid et al.
6627749 September 30, 2003 Kumar
6638285 October 28, 2003 Gabbay
6652594 November 25, 2003 Francis et al.
6656193 December 2, 2003 Grant et al.
6656200 December 2, 2003 Li et al.
6669735 December 30, 2003 Pelissier
6673093 January 6, 2004 Sawhney
6677258 January 13, 2004 Carroll et al.
6685714 February 3, 2004 Rousseau
6702828 March 9, 2004 Whayne
6703047 March 9, 2004 Sawhney et al.
6704210 March 9, 2004 Myers
6723114 April 20, 2004 Shalaby
6726706 April 27, 2004 Dominguez
6736823 May 18, 2004 Darois et al.
6736854 May 18, 2004 Vadurro et al.
6746458 June 8, 2004 Cloud
6746869 June 8, 2004 Pui et al.
6764720 July 20, 2004 Pui et al.
6773458 August 10, 2004 Brauker et al.
6818018 November 16, 2004 Sawhney
6896684 May 24, 2005 Monassevitch et al.
6927315 August 9, 2005 Heinecke et al.
6939358 September 6, 2005 Palacios et al.
6946196 September 20, 2005 Foss
6953139 October 11, 2005 Milliman et al.
6959851 November 1, 2005 Heinrich
7009034 March 7, 2006 Pathak et al.
7025772 April 11, 2006 Gellman et al.
7060087 June 13, 2006 DiMatteo et al.
7087065 August 8, 2006 Ulmsten et al.
7108701 September 19, 2006 Evens et al.
7128253 October 31, 2006 Mastri et al.
7128748 October 31, 2006 Mooradian
7134438 November 14, 2006 Makower et al.
7141055 November 28, 2006 Abrams et al.
7147138 December 12, 2006 Shelton, IV
7160299 January 9, 2007 Baily
7179268 February 20, 2007 Roy et al.
7210810 May 1, 2007 Iversen et al.
7232449 June 19, 2007 Sharkawy et al.
7241300 July 10, 2007 Sharkawy et al.
7247338 July 24, 2007 Pui et al.
7279322 October 9, 2007 Pui et al.
7307031 December 11, 2007 Carroll et al.
7311720 December 25, 2007 Mueller et al.
7334717 February 26, 2008 Rethy et al.
7334828 February 26, 2008 Budde et al.
7347850 March 25, 2008 Sawhney
7377928 May 27, 2008 Zubik et al.
7434717 October 14, 2008 Shelton, IV et al.
7438209 October 21, 2008 Hess et al.
7498063 March 3, 2009 Pui et al.
7547312 June 16, 2009 Bauman et al.
7559937 July 14, 2009 de la Torre et al.
7571845 August 11, 2009 Viola
7592418 September 22, 2009 Pathak et al.
7594921 September 29, 2009 Browning
7595392 September 29, 2009 Kumar et al.
7604151 October 20, 2009 Hess et al.
7611494 November 3, 2009 Campbell et al.
7635073 December 22, 2009 Heinrich
7649089 January 19, 2010 Kumar et al.
7662801 February 16, 2010 Kumar et al.
7665646 February 23, 2010 Prommersberger
7666198 February 23, 2010 Suyker et al.
7669747 March 2, 2010 Weisenburgh, II et al.
7717313 May 18, 2010 Criscuolo et al.
7722642 May 25, 2010 Williamson, IV et al.
7744627 June 29, 2010 Drban, III et al.
7776060 August 17, 2010 Mooradian et al.
7789889 September 7, 2010 Zubik et al.
7793813 September 14, 2010 Bettuchi
7799026 September 21, 2010 Schechter et al.
7823592 November 2, 2010 Bettuchi et al.
7824420 November 2, 2010 Eldridge et al.
7845533 December 7, 2010 Marczyk et al.
7845536 December 7, 2010 Viola et al.
7846149 December 7, 2010 Jankowski
7892247 February 22, 2011 Conston et al.
7909224 March 22, 2011 Prommersberger
7909837 March 22, 2011 Crews et al.
7938307 May 10, 2011 Bettuchi
7942890 May 17, 2011 D'Agostino et al.
7950561 May 31, 2011 Aranyi
7951166 May 31, 2011 Orban, III et al.
7951248 May 31, 2011 Fallis et al.
7967179 June 28, 2011 Olson et al.
7988027 August 2, 2011 Olson et al.
8011550 September 6, 2011 Aranyi et al.
8011555 September 6, 2011 Tarinelli et al.
8016177 September 13, 2011 Bettuchi et al.
8016178 September 13, 2011 Olson et al.
8025199 September 27, 2011 Whitman et al.
8028883 October 4, 2011 Stopek
8033483 October 11, 2011 Fortier et al.
8033983 October 11, 2011 Chu et al.
8038045 October 18, 2011 Bettuchi et al.
8062330 November 22, 2011 Prommersberger et al.
8062673 November 22, 2011 Figuly et al.
8083119 December 27, 2011 Prommersberger
8123766 February 28, 2012 Bauman et al.
8123767 February 28, 2012 Bauman et al.
8127975 March 6, 2012 Olson et al.
8133336 March 13, 2012 Kettlewell et al.
8133559 March 13, 2012 Lee et al.
8146791 April 3, 2012 Bettuchi et al.
8152777 April 10, 2012 Campbell et al.
8157149 April 17, 2012 Olson et al.
8157151 April 17, 2012 Ingmanson et al.
8167895 May 1, 2012 D'Agostino et al.
8178746 May 15, 2012 Hildeberg et al.
8192460 June 5, 2012 Orban, III et al.
8201720 June 19, 2012 Hessler
8210414 July 3, 2012 Bettuchi et al.
8210453 July 3, 2012 Hull et al.
8225799 July 24, 2012 Bettuchi
8225981 July 24, 2012 Criscuolo et al.
8231043 July 31, 2012 Tarinelli et al.
8235273 August 7, 2012 Olson et al.
8245901 August 21, 2012 Stopek
8252339 August 28, 2012 Figuly et al.
8252921 August 28, 2012 Vignon et al.
8256654 September 4, 2012 Bettuchi et al.
8257391 September 4, 2012 Orban, III et al.
8276800 October 2, 2012 Bettuchi
8286849 October 16, 2012 Bettuchi
8308042 November 13, 2012 Aranyi
8308045 November 13, 2012 Bettuchi et al.
8308046 November 13, 2012 Prommersberger
8312885 November 20, 2012 Bettuchi et al.
8313014 November 20, 2012 Bettuchi
8322590 December 4, 2012 Patel et al.
8348126 January 8, 2013 Olson et al.
8348130 January 8, 2013 Shah et al.
8365972 February 5, 2013 Aranyi et al.
8367089 February 5, 2013 Wan et al.
8371491 February 12, 2013 Huitema et al.
8371492 February 12, 2013 Aranyi et al.
8371493 February 12, 2013 Aranyi et al.
8393514 March 12, 2013 Shelton, IV et al.
8393517 March 12, 2013 Milo
8408440 April 2, 2013 Olson et al.
8408480 April 2, 2013 Hull et al.
8413869 April 9, 2013 Heinrich
8413871 April 9, 2013 Racenet et al.
8418909 April 16, 2013 Kostrzewski
8424742 April 23, 2013 Bettuchi
8453652 June 4, 2013 Stopek
8453904 June 4, 2013 Eskaros et al.
8453909 June 4, 2013 Olson et al.
8453910 June 4, 2013 Bettuchi et al.
8464925 June 18, 2013 Hull et al.
8470360 June 25, 2013 McKay
8474677 July 2, 2013 Woodard, Jr. et al.
8479968 July 9, 2013 Hodgkinson et al.
8485414 July 16, 2013 Criscuolo et al.
8496683 July 30, 2013 Prommersberger et al.
8511533 August 20, 2013 Viola et al.
8512402 August 20, 2013 Marczyk et al.
8518440 August 27, 2013 Blaskovich et al.
8529600 September 10, 2013 Woodard, Jr. et al.
8540131 September 24, 2013 Swayze
8551138 October 8, 2013 Orban, III et al.
8556918 October 15, 2013 Bauman et al.
8561873 October 22, 2013 Ingmanson et al.
8579990 November 12, 2013 Priewe
8584920 November 19, 2013 Hodgkinson
8590762 November 26, 2013 Hess et al.
8616430 December 31, 2013 (Prommersberger) Stopek et al.
8617132 December 31, 2013 Golzarian et al.
8631989 January 21, 2014 Aranyi et al.
8646674 February 11, 2014 Schulte et al.
8668129 March 11, 2014 Olson
8678263 March 25, 2014 Viola
8684250 April 1, 2014 Bettuchi et al.
8721703 May 13, 2014 Fowler
8757466 June 24, 2014 Olson et al.
8789737 July 29, 2014 Hodgkinson et al.
8814888 August 26, 2014 Sgro
8820606 September 2, 2014 Hodgkinson
8857694 October 14, 2014 Shelton, IV et al.
8864009 October 21, 2014 Shelton, IV et al.
8870050 October 28, 2014 Hodgkinson
8920443 December 30, 2014 Hiles et al.
8920444 December 30, 2014 Hiles et al.
8939344 January 27, 2015 Olson et al.
8967448 March 3, 2015 Carter et al.
9005243 April 14, 2015 Stopek et al.
9010606 April 21, 2015 Aranyi et al.
9010608 April 21, 2015 Casasanta, Jr. et al.
9010609 April 21, 2015 Carter et al.
9010610 April 21, 2015 Hodgkinson
9010612 April 21, 2015 Stevenson et al.
9016543 April 28, 2015 (Prommersberger) Stopek et al.
9016544 April 28, 2015 Hodgkinson et al.
9027817 May 12, 2015 Milliman et al.
9044227 June 2, 2015 Shelton, IV et al.
9055944 June 16, 2015 Hodgkinson et al.
9084602 July 21, 2015 Gleiman
9107665 August 18, 2015 Hodgkinson et al.
9107667 August 18, 2015 Hodgkinson
9113871 August 25, 2015 Milliman et al.
9113873 August 25, 2015 Marczyk et al.
9113885 August 25, 2015 Hodgkinson et al.
9113893 August 25, 2015 Sorrentino et al.
9161753 October 20, 2015 Prior
9161757 October 20, 2015 Bettuchi
9186140 November 17, 2015 Hiles et al.
9186144 November 17, 2015 Stevenson et al.
9192378 November 24, 2015 Aranyi et al.
9192379 November 24, 2015 Aranyi et al.
9192380 November 24, 2015 (Tarinelli) Racenet et al.
9192383 November 24, 2015 Milliman
9192384 November 24, 2015 Bettuchi
9198660 December 1, 2015 Hodgkinson
9198663 December 1, 2015 Marczyk et al.
9204881 December 8, 2015 Penna
9220504 December 29, 2015 Viola et al.
9226754 January 5, 2016 D'Agostino et al.
9237892 January 19, 2016 Hodgkinson
9237893 January 19, 2016 Carter et al.
9277922 March 8, 2016 Carter et al.
9295466 March 29, 2016 Hodgkinson et al.
9326768 May 3, 2016 Shelton, IV
9326773 May 3, 2016 Casasanta, Jr. et al.
9328111 May 3, 2016 Zhou et al.
9345479 May 24, 2016 (Tarinelli) Racenet et al.
9351729 May 31, 2016 Orban, III et al.
9351731 May 31, 2016 Carter
9351732 May 31, 2016 Hodgkinson
9358005 June 7, 2016 Shelton, IV et al.
9364229 June 14, 2016 D'Agostino et al.
9364234 June 14, 2016 (Prommersberger) Stopek et al.
9402627 August 2, 2016 Stevenson et al.
9414839 August 16, 2016 Penna
9433412 September 6, 2016 Bettuchi et al.
9433413 September 6, 2016 Stopek
9433420 September 6, 2016 Hodgkinson
9445812 September 20, 2016 Olson et al.
9445817 September 20, 2016 Bettuchi
9486215 November 8, 2016 Olson et al.
9504470 November 29, 2016 Milliman
9572576 February 21, 2017 Hodgkinson et al.
9597077 March 21, 2017 Hodgkinson
9610080 April 4, 2017 Whitfield et al.
9622745 April 18, 2017 Ingmanson et al.
9629626 April 25, 2017 Soltz et al.
9655620 May 23, 2017 Prescott et al.
9675351 June 13, 2017 Hodgkinson et al.
9681936 June 20, 2017 Hodgkinson et al.
9693772 July 4, 2017 Ingmanson et al.
9775617 October 3, 2017 Carter et al.
9775618 October 3, 2017 Bettuchi et al.
9782173 October 10, 2017 Mozdzierz
9844378 December 19, 2017 Casasanta et al.
9931116 April 3, 2018 Racenet et al.
10022125 July 17, 2018 (Prommersberger) Stopek et al.
10357249 July 23, 2019 Carter et al.
20020028243 March 7, 2002 Masters
20020086990 July 4, 2002 Kumar et al.
20020091397 July 11, 2002 Chen
20020151911 October 17, 2002 Gabbay
20020165559 November 7, 2002 Grant et al.
20020165562 November 7, 2002 Grant et al.
20020165563 November 7, 2002 Grant et al.
20030065345 April 3, 2003 Weadock
20030078209 April 24, 2003 Schmidt
20030083676 May 1, 2003 Wallace
20030120284 June 26, 2003 Palacios et al.
20030125676 July 3, 2003 Swenson et al.
20030181927 September 25, 2003 Wallace
20030183671 October 2, 2003 Mooradian et al.
20030196668 October 23, 2003 Harrison et al.
20030208231 November 6, 2003 Williamson et al.
20040092912 May 13, 2004 Jinno et al.
20040093029 May 13, 2004 Zubik et al.
20040107006 June 3, 2004 Francis et al.
20040131418 July 8, 2004 Budde et al.
20040254590 December 16, 2004 Hoffman et al.
20040254608 December 16, 2004 Huitema et al.
20040260315 December 23, 2004 Dell et al.
20050002981 January 6, 2005 Lahtinen et al.
20050021085 January 27, 2005 Abrams et al.
20050059996 March 17, 2005 Bauman
20050059997 March 17, 2005 Bauman et al.
20050070929 March 31, 2005 Dalessandro et al.
20050118435 June 2, 2005 DeLucia et al.
20050131225 June 16, 2005 Kumar et al.
20050143756 June 30, 2005 Jankowski
20050149073 July 7, 2005 Arani et al.
20050154093 July 14, 2005 Kwon et al.
20050228446 October 13, 2005 Mooradian et al.
20050245965 November 3, 2005 Orban, III et al.
20050283256 December 22, 2005 Sommerich et al.
20060004407 January 5, 2006 Hiles et al.
20060008505 January 12, 2006 Brandon
20060025816 February 2, 2006 Shelton
20060085030 April 20, 2006 Bettuchi et al.
20060093672 May 4, 2006 Kumar et al.
20060111738 May 25, 2006 Wenchell
20060121266 June 8, 2006 Fandel et al.
20060135992 June 22, 2006 Bettuchi et al.
20060173470 August 3, 2006 Oray et al.
20060178683 August 10, 2006 Shimoji et al.
20060190027 August 24, 2006 Downey
20060219752 October 5, 2006 Arad et al.
20060271104 November 30, 2006 Viola et al.
20070026031 February 1, 2007 Bauman et al.
20070027550 February 1, 2007 Farnsworth
20070027552 February 1, 2007 Farnsworth
20070034669 February 15, 2007 de la Torre et al.
20070049953 March 1, 2007 Shimoji et al.
20070054880 March 8, 2007 Saferstein et al.
20070114262 May 24, 2007 Mastri et al.
20070123839 May 31, 2007 Rousseau et al.
20070175961 August 2, 2007 Shelton et al.
20070179528 August 2, 2007 Soltz et al.
20070203509 August 30, 2007 Bettuchi
20070203510 August 30, 2007 Bettuchi
20070213522 September 13, 2007 Harris et al.
20070243227 October 18, 2007 Gertner
20070246505 October 25, 2007 Pace-Floridia et al.
20070297987 December 27, 2007 Stad et al.
20080009811 January 10, 2008 Cantor
20080029570 February 7, 2008 Shelton et al.
20080082126 April 3, 2008 Murray et al.
20080110959 May 15, 2008 Orban et al.
20080125812 May 29, 2008 Zubik et al.
20080140115 June 12, 2008 Stopek
20080161831 July 3, 2008 Bauman et al.
20080161832 July 3, 2008 Bauman et al.
20080164440 July 10, 2008 Maase et al.
20080169327 July 17, 2008 Shelton et al.
20080169328 July 17, 2008 Shelton
20080169329 July 17, 2008 Shelton et al.
20080169330 July 17, 2008 Shelton et al.
20080169331 July 17, 2008 Shelton et al.
20080169332 July 17, 2008 Shelton et al.
20080169333 July 17, 2008 Shelton et al.
20080200949 August 21, 2008 Hiles et al.
20080216855 September 11, 2008 Nasca
20080220047 September 11, 2008 Sawhney et al.
20080230583 September 25, 2008 Heinrich
20080290134 November 27, 2008 Bettuchi et al.
20080308608 December 18, 2008 Prommersberger
20080314960 December 25, 2008 Marczyk et al.
20090001121 January 1, 2009 Hess et al.
20090001122 January 1, 2009 Prommersberger et al.
20090001123 January 1, 2009 Morgan et al.
20090001124 January 1, 2009 Hess et al.
20090001125 January 1, 2009 Hess et al.
20090001126 January 1, 2009 Hess et al.
20090001128 January 1, 2009 Weisenburgh, II et al.
20090001130 January 1, 2009 Hess et al.
20090005808 January 1, 2009 Hess et al.
20090030452 January 29, 2009 Bauman et al.
20090031842 February 5, 2009 Kawai et al.
20090043334 February 12, 2009 Bauman et al.
20090076510 March 19, 2009 Bell et al.
20090076528 March 19, 2009 Sgro
20090078739 March 26, 2009 Viola
20090095791 April 16, 2009 Eskaros et al.
20090095792 April 16, 2009 Bettuchi
20090120994 May 14, 2009 Murray et al.
20090134200 May 28, 2009 Farinelli et al.
20090206125 August 20, 2009 Huitema et al.
20090206126 August 20, 2009 Huitema et al.
20090206139 August 20, 2009 Hall et al.
20090206141 August 20, 2009 Huitema et al.
20090206142 August 20, 2009 Huitema et al.
20090206143 August 20, 2009 Huitema
20090218384 September 3, 2009 Aranyi
20090277944 November 12, 2009 Dalessandro et al.
20090277947 November 12, 2009 Viola
20090287230 November 19, 2009 D'Agostino et al.
20100012704 January 21, 2010 Tarinelli Racenet et al.
20100016855 January 21, 2010 Ramstein et al.
20100016872 January 21, 2010 Bayon et al.
20100016888 January 21, 2010 Calabrese et al.
20100065606 March 18, 2010 Stopek
20100065607 March 18, 2010 Orban, III et al.
20100072254 March 25, 2010 Aranyi et al.
20100087840 April 8, 2010 Ebersole et al.
20100147921 June 17, 2010 Olson
20100147922 June 17, 2010 Olson
20100147923 June 17, 2010 D'Agostino et al.
20100174253 July 8, 2010 Cline et al.
20100203151 August 12, 2010 Hiraoka
20100243707 September 30, 2010 Olson et al.
20100243708 September 30, 2010 Aranyi et al.
20100243711 September 30, 2010 Olson et al.
20100249805 September 30, 2010 Olson et al.
20100264195 October 21, 2010 Bettuchi
20100278891 November 4, 2010 Ringeisen
20100282815 November 11, 2010 Bettuchi et al.
20100331859 December 30, 2010 Omori
20100331880 December 30, 2010 Stopek
20110024476 February 3, 2011 Bettuchi et al.
20110024481 February 3, 2011 Bettuchi et al.
20110034910 February 10, 2011 Ross et al.
20110036894 February 17, 2011 Bettuchi
20110042442 February 24, 2011 Viola et al.
20110046650 February 24, 2011 Bettuchi
20110057016 March 10, 2011 Bettuchi
20110087279 April 14, 2011 Shah et al.
20110089220 April 21, 2011 Ingmanson et al.
20110089375 April 21, 2011 Chan et al.
20110125138 May 26, 2011 Malinouskas et al.
20110166673 July 7, 2011 Patel et al.
20110215132 September 8, 2011 Aranyi et al.
20110278346 November 17, 2011 Hull et al.
20110278347 November 17, 2011 Olson et al.
20110282446 November 17, 2011 Schulte
20110293690 December 1, 2011 Griffin et al.
20120035629 February 9, 2012 Sherwinter
20120074199 March 29, 2012 Olson et al.
20120080336 April 5, 2012 Shelton, IV et al.
20120080491 April 5, 2012 Shelton, IV
20120083723 April 5, 2012 Vitaris et al.
20120145767 June 14, 2012 Shah et al.
20120187179 July 26, 2012 Gleiman
20120197272 August 2, 2012 Oray et al.
20120241491 September 27, 2012 Aldridge et al.
20120241493 September 27, 2012 Baxter, III et al.
20120241499 September 27, 2012 Baxter, III et al.
20120253298 October 4, 2012 Henderson et al.
20120273547 November 1, 2012 Hodgkinson et al.
20130037596 February 14, 2013 Bear et al.
20130075447 March 28, 2013 Weisenburgh, II
20130105548 May 2, 2013 Hodgkinson et al.
20130105553 May 2, 2013 (Tarinelli) Racenet et al.
20130112732 May 9, 2013 Aranyi et al.
20130112733 May 9, 2013 Aranyi et al.
20130123816 May 16, 2013 Hodgkinson et al.
20130146641 June 13, 2013 Shelton, IV et al.
20130153633 June 20, 2013 Casasanta, Jr. et al.
20130153634 June 20, 2013 Carter et al.
20130153635 June 20, 2013 Hodgkinson
20130153636 June 20, 2013 Shelton, IV et al.
20130153639 June 20, 2013 Hodgkinson et al.
20130153640 June 20, 2013 Hodgkinson
20130153641 June 20, 2013 Shelton, IV et al.
20130161374 June 27, 2013 Swayze et al.
20130181031 July 18, 2013 Olson et al.
20130193186 August 1, 2013 (Tarinelli) Racenet et al.
20130193190 August 1, 2013 Carter et al.
20130193191 August 1, 2013 Stevenson et al.
20130193192 August 1, 2013 Casasanta, Jr. et al.
20130209659 August 15, 2013 Racenet et al.
20130221062 August 29, 2013 Hodgkinson
20130240600 September 19, 2013 Bettuchi
20130240601 September 19, 2013 Bettuchi et al.
20130240602 September 19, 2013 Stopek
20130256380 October 3, 2013 Schmid et al.
20130277411 October 24, 2013 Hodgkinson et al.
20130306707 November 21, 2013 Viola et al.
20130310873 November 21, 2013 Stopek et al.
20130327807 December 12, 2013 Olson et al.
20140012317 January 9, 2014 Orban et al.
20140021242 January 23, 2014 Hodgkinson et al.
20140027490 January 30, 2014 Marczyk et al.
20140034704 February 6, 2014 Ingmanson et al.
20140048580 February 20, 2014 Merchant et al.
20140061280 March 6, 2014 Ingmanson et al.
20140061281 March 6, 2014 Hodgkinson
20140084042 March 27, 2014 (Prommersberger) Stopek et al.
20140097224 April 10, 2014 Prior
20140117066 May 1, 2014 Aranyi et al.
20140130330 May 15, 2014 Olson et al.
20140131418 May 15, 2014 Kostrzewski
20140131419 May 15, 2014 Bettuchi
20140138423 May 22, 2014 Whitfield et al.
20140151431 June 5, 2014 Hodgkinson et al.
20140155916 June 5, 2014 Hodgkinson et al.
20140158742 June 12, 2014 Stopek et al.
20140166721 June 19, 2014 Stevenson et al.
20140197224 July 17, 2014 Penna
20140203061 July 24, 2014 Hodgkinson
20140217147 August 7, 2014 Milliman
20140217148 August 7, 2014 Penna
20140239046 August 28, 2014 Milliman
20140239047 August 28, 2014 Hodgkinson et al.
20140252062 September 11, 2014 Mozdzierz
20150001276 January 1, 2015 Hodgkinson et al.
20150041347 February 12, 2015 Hodgkinson
20150097018 April 9, 2015 Hodgkinson
20150115015 April 30, 2015 Prescott et al.
20150122872 May 7, 2015 Olson et al.
20150133995 May 14, 2015 Shelton, IV et al.
20150164503 June 18, 2015 Stevenson et al.
20150164506 June 18, 2015 Carter et al.
20150164507 June 18, 2015 Carter et al.
20150196297 July 16, 2015 (Prommersberger) Stopek et al.
20150209033 July 30, 2015 Hodgkinson
20150209045 July 30, 2015 Hodgkinson et al.
20150209048 July 30, 2015 Carter et al.
20150231409 August 20, 2015 Racenet et al.
20150305743 October 29, 2015 Casasanta et al.
20150327864 November 19, 2015 Hodgkinson et al.
20160022268 January 28, 2016 Prior
20160045200 February 18, 2016 Milliman
20160058451 March 3, 2016 (Tarinelli) Racenet et al.
20160100834 April 14, 2016 Viola et al.
20160106430 April 21, 2016 Carter et al.
20160113647 April 28, 2016 Hodgkinson
20160157857 June 9, 2016 Hodgkinson et al.
20160174988 June 23, 2016 D'Agostino et al.
20160206315 July 21, 2016 Olson
20160220257 August 4, 2016 Casasanta et al.
20160249923 September 1, 2016 Hodgkinson et al.
20160256166 September 8, 2016 (Prommersberger) Stopek et al.
20160270793 September 22, 2016 Carter et al.
20160310143 October 27, 2016 Bettuchi
20160338704 November 24, 2016 Penna
20160367252 December 22, 2016 Olson et al.
20160367253 December 22, 2016 Hodgkinson
20160367257 December 22, 2016 Stevenson et al.
20170042540 February 16, 2017 Olson et al.
20170049452 February 23, 2017 Milliman
20170150967 June 1, 2017 Hodgkinson et al.
20170172575 June 22, 2017 Hodgkinson
20170231629 August 17, 2017 Stopek et al.
20170238931 August 24, 2017 Prescott et al.
20170281328 October 5, 2017 Hodgkinson et al.
20170296188 October 19, 2017 Ingmanson et al.
20170354415 December 14, 2017 Casasanta, Jr. et al.
20180125491 May 10, 2018 Aranyi
20180140301 May 24, 2018 Milliman
20180168654 June 21, 2018 Hodgkinson et al.
20180214147 August 2, 2018 Merchant et al.
Foreign Patent Documents
2012201677 November 2012 AU
2013200367 September 2013 AU
2 667 434 May 2008 CA
1301685 February 2007 CN
101310680 November 2008 CN
101332110 December 2008 CN
1602563 March 1950 DE
19924311 November 2000 DE
0327022 August 1989 EP
0594148 April 1994 EP
0667119 August 1995 EP
1064883 January 2001 EP
1256317 November 2002 EP
1256318 November 2002 EP
1520525 April 2005 EP
1621141 February 2006 EP
1702570 September 2006 EP
1759640 March 2007 EP
1815804 August 2007 EP
1825820 August 2007 EP
1929958 June 2008 EP
1994890 November 2008 EP
2005894 December 2008 EP
2005895 December 2008 EP
2008595 December 2008 EP
2039308 March 2009 EP
2090231 August 2009 EP
2090244 August 2009 EP
2090252 August 2009 EP
2163211 March 2010 EP
2189121 May 2010 EP
2198787 June 2010 EP
2236098 October 2010 EP
2236099 October 2010 EP
2258282 December 2010 EP
2292276 March 2011 EP
2311386 April 2011 EP
2436348 April 2012 EP
2462880 June 2012 EP
2491867 August 2012 EP
2497431 September 2012 EP
2517637 October 2012 EP
2586380 May 2013 EP
2604195 June 2013 EP
2604197 June 2013 EP
2620105 July 2013 EP
2620106 July 2013 EP
2630922 August 2013 EP
2644125 October 2013 EP
2762091 August 2014 EP
654857 March 1994 JP
07124166 May 1995 JP
2000166933 June 2000 JP
2002202213 July 2002 JP
2002369820 December 2002 JP
2005508796 April 2005 JP
2007505708 March 2007 JP
2008528203 July 2008 JP
2009189846 August 2009 JP
2010528821 August 2010 JP
9005489 May 1990 WO
95/16221 June 1995 WO
9622055 July 1996 WO
9701989 January 1997 WO
9713463 April 1997 WO
9817180 April 1998 WO
98/38923 September 1998 WO
9945849 September 1999 WO
03082126 October 2003 WO
03088845 October 2003 WO
03094743 November 2003 WO
03105698 December 2003 WO
2005079675 September 2005 WO
2006023578 March 2006 WO
2006044490 April 2006 WO
2006083748 August 2006 WO
2007121579 November 2007 WO
2008057281 May 2008 WO
2008109125 September 2008 WO
2008157172 December 2008 WO
2010075298 July 2010 WO
2011143183 November 2011 WO
2012044848 April 2012 WO
Other references
  • Extended European Search Report corresponding to EP 13 18 7911.6, completed Jan. 22, 2014 and dated Jan. 31, 2014; (8 pp).
  • Extended European Search Report corresponding to EP 13 19 2111.6, completed Feb. 13, 2014 and dated Feb. 27, 2014; (10 pp).
  • Extended European Search Report corresponding to EP 13 19 5919.9, completed Feb. 10, 2014 and dated Mar. 3, 2014; (7 pp).
  • Extended European Search Report corresponding to EP 08 72 6500.5, completed Feb. 20, 2014 and dated Mar. 3, 2014; (7 pp).
  • Extended European Search Report corresponding to EP 13 19 5019.8, completed Mar. 14, 2014 and dated Mar. 24, 2014; (7 pp).
  • Extended European Search Report corresponding to EP 13 19 6816.6, completed Mar. 28, 2014 and dated Apr. 9, 2014; (9 pp).
  • Extended European Search Report corresponding to EP 13 19 7958.5, completed Apr. 4, 2014 and dated Apr. 15, 2014; (8 pp).
  • Extended European Search Report corresponding to EP 13 19 4995.0, completed Jun. 5, 2014 and dated Jun. 16, 2014; (5 pp).
  • Extended European Search Report corresponding to EP 14 15 7195.0, completed Jun. 5, 2014 and dated Jun. 18, 2014; (9 pp).
  • Extended European Search Report corresponding to EP 14 15 6342.9, completed Jul. 22, 2014 and dated Jul. 29, 2014; (8 pp).
  • Extended European Search Report corresponding to EP 14 16 9739.1, completed Aug. 19, 2014 and Aug. 29, 2014; (7 pp).
  • Extended European Search Report corresponding to EP 14 15 7997.9, completed Sep. 9, 2014 and dated Sep. 17, 2014; (8 pp).
  • Extended European Search Report corresponding to EP 14 16 8904.2, completed Sep. 10, 2014 and dated Sep. 18, 2014; (8 pp).
  • Extended European Search Report corresponding to EP 13 19 4995.0, completed Jun. 5, 2014 and dated Oct. 13, 2014; (10 pp).
  • Extended European Search Report corresponding to EP 13 15 4571.7, completed Oct. 10, 2014 and dated Oct. 20, 2014; (8 pp).
  • Extended European Search Report corresponding to EP 14 18 1125.7, completed Oct. 16, 2014 and dated Oct. 24, 2014; (7 pp).
  • Extended European Search Report corresponding to EP 14 18 1127.3, completed Oct. 16, 2014 and dated Nov. 10, 2014; (8 pp).
  • Extended European Search Report corresponding to EP 14 19 0419.3, completed Mar. 24, 2015 and dated Mar. 30, 2015; (6 pp).
  • European Office Action corresponding to counterpart Int'l Appln No. EP 12 198 776.2 dated Apr. 7, 2015.
  • European Office Action corresponding to counterpart Int'l Appln No. EP 13 156 297.7 dated Apr. 10, 2015.
  • Australian Examination Report No. 1 corresponding to counterpart Int'l Appln No. AU 2011250822 dated May 18, 2015.
  • European Office Action corresponding to counterpart Int'l Appln No. EP 12 186 175.1 dated Jun. 1, 2015.
  • Chinese Office Action corresponding to counterpart Int'l Appln No. CN 201010517292.8 dated Jun. 2, 2015.
  • Extended European Search Report corresponding to counterpart Int'l Appln No. EP 14 17 4814.5 dated Jun. 9, 2015.
  • Australian Examination Report No. 1 corresponding to counterpart Int'l Appln No. AU 2014200584 dated Jun. 15, 2015.
  • European Office Action corresponding to counterpart Int'l Appln No. EP 13 180 881.8 dated Jun. 19, 2015.
  • European Office Action corresponding to counterpart Int'l Appln No. EP 14 157 195.0 dated Jul. 2, 2015.
  • Extended European Search Report corresponding to counterpart Int'l Appln No. EP 12 19 6902.6 dated Aug. 6, 2015.
  • Extended European Search Report corresponding to counterpart Int'l Appln No. EP 14 15 2060.1 dated Aug. 14, 2015.
  • Chinese Office Action corresponding to counterpart Int'l Appln No. CN 201210129787.2 dated Aug. 24, 2015.
  • Canadian Office Action corresponding to counterpart Int'l Appln. No. CA 2,665,206 dated Nov. 19, 2013.
  • Chinese Notification of Reexamination corresponding to counterpart Int'l Appln. No. CN 201010517292.8 dated Jun. 2, 2015.
  • Japanese Office Action corresponding to counterpart Int'l Appln. No. JP 2014-216989 dated Sep. 11, 2015.
  • Canadian First Office Action corresponding to counterpart Int'l Appln. No. CA 2,686,105 dated Sep. 17, 2015.
  • Japanese Office Action corresponding to counterpart Int'l Appln. No. JP 2012-040188 dated Oct. 21, 2015.
  • European Communication corresponding to counterpart Int'l Appln. No. EP 13 17 6895.4 dated Nov. 5, 2015.
  • Chinese First Office Action corresponding to counterpart Int'l Appln. No. CN 201210544552 dated Nov. 23, 2015.
  • Chinese First Office Action corresponding to counterpart Int'l Appln. No. CN 201210545228 dated Nov. 30, 2015.
  • Extended European Search Report corresponding to counterpart Int'l Appln. No. EP 15 18 0491.1 dated Dec. 9, 2015.
  • Extended European Search Report corresponding to counterpart Int'l Appln. No. EP 15 18 3819.0 dated Dec. 11, 2015.
  • Canadian Office Action corresponding to counterpart Int'l Appln. No. CA 2,697,819 dated Jan. 6, 2016.
  • Canadian Office Action corresponding to counterpart Int'l Appln. No. CA 2,696,419 dated Jan. 14, 2016.
  • European Office Action corresponding to counterpart Int'l Appln. No. EP 12 19 8776.2 dated Jan. 19, 2016.
  • Extended European Search Report corresponding to counterpart Int'l Appln. No. EP 15 17 4146.9 dated Jan. 20, 2016.
  • Chinese First Office Action corresponding to counterpart Int'l Appln. No. CN 201310353628.5 dated Jan. 25, 2016.
  • Extended European Search Report corresponding to counterpart Int'l Appln. No. EP 12 19 6912.5 dated Feb. 1, 2016.
  • Japanese Office Action corresponding to counterpart Int'l Appln. No. JP 2012-098903 dated Feb. 22, 2016.
  • Extended European Search Report corresponding to counterpart Int'l Appln. No. EP 12 19 8753.1 dated Feb. 24, 2016.
  • Chinese First Office Action corresponding to counterpart Int'l Appln. No. CN 201410449019.4 dated Mar. 30, 2016.
  • Extended European Search Report corresponding to counterpart Int'l Appln. No. EP 16150232.3, dated Apr. 12, 2016.
  • Canadian Office Action dated Nov. 7, 2019 corresponding to counterpart Patent Application CA 2,837,451.
  • European Office Action corresponding to counterpart Int'l Appln. No. EP 11 18 3256.4 dated Apr. 20, 2016.
  • Australian Examination Report No. 1 corresponding to counterpart Int'l Appln. No AU 2012244169 dated May 10, 2016.
  • European Office Action corresponding to counterpart Int'l Appln. No. EP 10 25 0715.9 dated May 12, 2016.
  • Chinese First Office Action corresponding to counterpart Int'l Appln. No. CN 201410778512.0 dated May 13, 2016.
  • Australian Examination Report No. 1 corresponding to counterpart Int'l Appln. No. AU 2012227358 dated May 16, 2016.
  • Japanese Office Action corresponding to counterpart Int'l Appln. No. JP 2012-040188 dated May 17, 2016.
  • Australian Examination Report No. 1 corresponding to counterpart Int'l Appln. No. AU 2012244380 dated May 20, 2016.
  • Japanese Notice of Allowance corresponding to counterpart Patent Appln. JP 2013-250857 dated Apr. 2, 2018.
  • Japanese Office Action corresponding to counterpart Int'l Appln. No. JP 2013-154561 dated May 23, 2017.
  • Chinese First Office Action corresponding to counterpart Int'l Appln. No. CN 201310646606.8 dated Dec. 23, 2016.
  • Japanese Office Action corresponding to counterpart Int'l Appln. No. JP 2013-000321 dated Jan. 4, 2017.
  • Extended European Search Report corresponding to counterpart Int'l Appln. No. EP 16 16 6367.9 dated Jan. 16, 2017.
  • Australian Examination Report No. 1 corresponding to counterpart Int'l Appln. No. AU 2013206777 dated Feb. 1, 2017.
  • Chinese Second Office Action corresponding to counterpart Int'l Appln. No. CN 2013103036903 dated Feb. 23, 2017.
  • Japanese Office Action corresponding to counterpart Int'l Appln. No. JP 2013-175379 dated Mar. 1, 2017.
  • Chinese First Office Action corresponding to counterpart Int'l Appln. No. CN 201410028462.4 dated Mar. 2, 2017.
  • Chinese First Office Action corresponding to counterpart Int'l Appln. No. CN 201410084070 dated Mar. 13, 2017.
  • Extended European Search Report corresponding to counterpart Int'l Appln. No. EP 16 19 6549.6 dated Mar. 17, 2017.
  • Japanese Office Action corresponding to counterpart Int'l Appln. No. JP 2013-147701 dated Mar. 21, 2017.
  • Australian Examination Report No. 1 corresponding to counterpart Int'l Appln. No. AU 2013211499 dated May 4, 2017.
  • Australian Examination Report No. 1 corresponding to counterpart Int'l Appln. No. AU 2014201008 dated May 23, 2017.
  • Chinese Second Office Action corresponding to counterpart Int'l Appln. No. CN 201310353628.5 dated Sep. 26, 2016.
  • Chinese First Office Action corresponding to counterpart Int'l Appln. No. CN 2013107068710 dated Dec. 16, 2016.
  • Australian Examination Report No. 1 corresponding to counterpart Int'l Appln. No. AU 2013206804 dated Mar. 21, 2017.
  • Australian Examination Report No. 1 corresponding to counterpart Int'l Appln. No. AU 2014227480 dated May 21, 2016.
  • Australian Examination Report No. 1 corresponding to counterpart Int'l Appln. No. AU 2012254977 dated May 30, 2016.
  • Extended European Search Report corresponding to counterpart Int'l Appln. No. EP 16 15 3647.9 dated Jun. 3, 2016.
  • Australian Examination Report No. 1 corresponding to counterpart Int'l Appln. AU 2012244382 dated Jul. 10, 2016.
  • European Office Action corresponding to counterpart Int'l Appln. No. EP 14 17 2681.0 dated May 13, 2016.
  • Chinese Office Action corresponding to counterpart Int'l Appln. No. CN 201210545228 dated Jun. 29, 2016.
  • Japanese Office Action corresponding to counterpart Int'l Appln. No. JP 2012-250058 dated Jun. 29, 2016.
  • European Office Action corresponding to counterpart Int'l Appln. No. EP 14 15 7997.9 dated Jun. 29, 2016.
  • Canadian Office Action corresponding to counterpart Int'l Appln. No. CA 2,712,617 dated Jun. 30, 2016.
  • Chinese First Office Action corresponding to counterpart Int'l Appln. No. CN 2013103036903 dated Jun. 30, 2016.
  • Australian Patent Examination Report No. 1 corresponding to counterpart Int'l Appln. No. AU 2012250278 dated Jul. 10, 2016.
  • Australian Patent Examination Report No. 1 corresponding to counterpart Int'l Appln. No. AU 2012244382 dated Jul. 10, 2016.
  • Japanese Office Action corresponding to counterpart Int'l Appln. No. JP 2012-255242 dated Jul. 26, 2016.
  • Japanese Office Action corresponding to counterpart Int'l Appln. No. JP 2012-268668 dated Jul. 27, 2016.
  • European Office Action corresponding to counterpart Int'l Appln. No. EP 14 15 2060.1 dated Aug. 4, 2016.
  • European Office Action corresponding to counterpart Int'l Appln. No. EP 12 16 5609.4 dated Aug. 5, 2016.
  • European Office Action corresponding to counterpart Int'l Appln. No. EP 15 15 2392.5 dated Aug. 8, 2016.
  • Japanese Office Action corresponding to counterpart Int'l Appln. No. JP 2013-003624 dated Aug. 25, 2016.
  • Australian Patent Examination Report No. 1 corresponding to counterpart Int'l Appln. No. AU 2012261752 dated Sep. 6, 2016.
  • Japanese Office Action corresponding to counterpart Int'l Appln. No. JP 2014-252703 dated Sep. 26, 2016.
  • European Office Action corresponding to counterpart Int'l Appln. No. EP 12 19 8776.2 dated Sep. 12, 2016.
  • Japanese Office Action corresponding to counterpart Int'l Appln. No. JP 2013-000321 dated Sep. 13, 2016.
  • European Office Action corresponding to counterpart Int'l Appln. No. EP 12 15 2541.4 dated Sep. 27, 2016.
  • Australian Patent Examination Report No. 1 corresponding to counterpart Int'l Appln. No. AU 2012268923 dated Sep. 28, 2016.
  • Japanese Office Action corresponding to counterpart Int'l Appln. No. JP 2013-250857 dated Aug. 17, 2017.
  • Japanese Office Action corresponding to counterpart Japanese Patent Appln. No. JP 2013-154561 dated Jan. 15, 2018.
  • European Office Action corresponding to counterpart European Patent Application No. EP 13 19 7958.5 dated Dec. 11, 2017.
  • Chinese First Office Action corresponding to Patent Application CN 201410588811.8 dated Dec. 5, 2017.
  • European Office Action corresponding to Patent Application EP 16 16 6367.9 dated Dec. 11, 2017.
  • Chinese First Office Action corresponding to Patent Application CN 201610279682.3 dated Jan. 10, 2018.
  • Australian Examination Report No. 1 corresponding to Patent Application AU 2017225037 dated Jan. 23, 2018.
  • Japanese Office Action corresponding to Patent Application JP 2013-229471 dated May 1, 2018.
  • Canadian Office Action corresponding to Patent Application CA 2,790,743 dated May 14, 2018.
  • European Office Action corresponding to Patent Application EP 14 15 7195.0 dated Jun. 12, 2018.
  • “What is Ultrasonic Welding?”, http://www.dukane.com/us/PPL.sub.-whatisUPA.htm, Mar. 14, 2010.
  • International Search Report corresponding to European Application No. EP 05 02 2585.3, completed on Jan. 25, 2006 and dated Feb. 3, 2006; 4 pages.
  • European Search Report corresponding to EP 06 00 4598, completed Jun. 22, 2006; (2 pp).
  • European Search Report corresponding to EP 06 01 6962.0, completed Jan. 3, 2007 and dated Jan. 11, 2007; (10 pp).
  • International Search Report corresponding to International Application No. PCT/US2005/036740, completed Feb. 20, 2007 and dated Mar. 23, 2007; (8 pp).
  • International Search Report corresponding to International Application No. PCT/US2007/022713, completed Apr. 21, 2008 and dated May 15, 2008; (1 p).
  • International Search Report corresponding to International Application No. PCT/US2008/002981, completed Jun. 9, 2008 and dated Jun. 26, 2008; (2 pp).
  • European Search Report corresponding to EP 08 25 1779, completed Jul. 14, 2008 and dated Jul. 23, 2008; (5 pp).
  • European Search Report corresponding to EP 08 25 1989.3, completed Mar. 11, 2010 and dated Mar. 24, 2010; (6 pp).
  • European Search Report corresponding to EP 10 25 0639.1, completed Jun. 17, 2010 and dated Jun. 28, 2010; (7 pp).
  • European Search Report corresponding to EP 10 25 0715.9, completed Jun. 30, 2010 and dated Jul. 20, 2010; (3 pp).
  • European Search Report corresponding to EP 05 80 4382.9, completed Oct. 5, 2010 and dated Oct. 12, 2010; (3 pp).
  • European Search Report corresponding to EP 09 25 2897.5, completed Feb. 7, 2011 and dated Feb. 15, 2011; (3 pp).
  • European Search Report corresponding to EP 10 25 0642.5, completed Mar. 25, 2011 and dated Apr. 4, 2011; (4 pp).
  • European Search Report corresponding to EP 12 15 2229.6, completed Feb. 23, 2012 and dated Mar. 1, 2012; (4 pp).
  • European Search Report corresponding to EP 12 15 0511.9, completed Apr. 16, 2012 and dated Apr. 24, 2012; (7 pp).
  • European Search Report corresponding to EP 12 15 2541.4, completed Apr. 23, 2012 and dated May 3, 2012; (10 pp).
  • European Search Report corresponding to EP 12 16 5609.4, completed Jul. 5, 2012 and dated Jul. 13, 2012; (8 pp).
  • European Search Report corresponding to EP 12 15 8861.0, completed Jul. 17, 2012 and dated Jul. 24, 2012; (9 pp).
  • European Search Report corresponding to EP 12 16 5878.5, completed Jul. 24, 2012 and dated Aug. 6, 2012; (8 pp).
  • Extended European Search Report corresponding to EP 12 19 1035.0, completed Jan. 11, 2013 and dated Jan. 18, 2013; (7 pp).
  • Extended European Search Report corresponding to EP 12 18 6175.1, completed Jan. 15, 2013 and dated Jan. 23, 2013; (7 pp).
  • Extended European Search Report corresponding to EP 12 19 1114.3, completed Jan. 23, 2013 and dated Jan. 31, 2013; (10 pp).
  • Extended European Search Report corresponding to EP 12 19 2224.9, completed Mar. 14, 2013 and dated Mar. 26, 2013; (8 pp).
  • Extended European Search Report corresponding to EP 12 19 6904.2, completed Mar. 28, 2013 and dated Jul. 26, 2013; (8 pp).
  • Extended European Search Report corresponding to EP 12 19 6911.7, completed Apr. 18, 2013 and dated Apr. 24, 2013; (8 pp).
  • Extended European Search Report corresponding to EP 07 00 5842.5, completed May 13, 2013 and dated May 29, 2013; (7 pp).
  • Extended European Search Report corresponding to EP 12 19 8776.2, completed May 16, 2013 and dated May 27, 2013; (8 pp).
  • Extended European Search Report corresponding to EP 12 19 8749.9, completed May 21, 2013 and dated May 31, 2013; (8 pp).
  • Extended European Search Report corresponding to EP 13 15 6297.7, completed Jun. 4, 2013 and dated Jun. 13, 20131; (7 pp).
  • Extended European Search Report corresponding to EP 13 17 3985.6, completed Aug. 19, 2013 and dated Aug. 28, 2013; (6 pp).
  • Extended European Search Report corresponding to EP 13 17 3986.4, completed Aug. 20, 2013 and dated Aug. 29, 2013; (6 pp).
  • Extended European Search Report corresponding to EP 13 17 7437.4, completed Sep. 11, 2013 and dated Sep. 19, 2013; 6 pages.
  • Extended European Search Report corresponding to EP 13 17 7441.6, completed Sep. 11, 2013 and dated Sep. 19, 2013; (6 pp).
  • Extended European Search Report corresponding to EP 07 86 1534.1, completed Sep. 20, 2013 and dated Sep. 30, 2013; (5 pp).
  • Extended European Search Report corresponding to EP 13 18 3876.5, completed Oct. 14, 2013 and dated Oct. 24, 2013; (5 pp).
  • Extended European Search Report corresponding to EP 13 17 1856.1, completed Oct. 29, 2013 and dated Nov. 7, 2013; (8 pp).
  • Extended European Search Report corresponding to EP 13 18 0373.6, completed Oct. 31, 2013 and dated Nov. 13, 2013; (7 pp).
  • Extended European Search Report corresponding to EP 13 18 0881.8, completed Nov. 5, 2013 and dated Nov. 14, 2013; (6 pp).
  • Extended European Search Report corresponding to EP 13 17 6895.4, completed Nov. 29, 2013 and dated Dec. 12, 2013; (5 pp).
  • Extended European Search Report corresponding to EP 13 18 2911.1, completed Dec. 2, 2013 and dated Dec. 16, 2013; (8 pp).
  • Extended European Search Report corresponding to EP 10 25 1795.0, completed Dec. 11, 2013 and dated Dec. 20, 2013; (6 pp).
  • European Office Action corresponding to counterpart European Appln. No. EP 15 17 4146.9 dated May 15, 2017.
  • Japanese Office Action corresponding to counterpart Japanese Appln. No. JP 2013-154561 dated May 23, 2017.
  • European Office Action corresponding to counterpart European Appln. No. EP 12 19 4784.0 dated May 29, 2017.
  • Office Action corresponding to counterpart Japanese Appln. No. JP 2013-169083 dated May 31, 2017.
  • Australian Examination Report No. 1 corresponding to counterpart Australian Appln. No. AU 2013213767 dated Jun. 29, 2017.
  • Australian Examination Report No. 2 corresponding to counterpart Australian Appln. No. AU 2012261752 dated Jul. 7, 2017.
  • Australian Examination Report No. 1 corresponding to counterpart Australian Appln. No. AU 2013266989 dated Jul. 10, 2017.
  • Extended European Search Report corresponding to counterpart European Appln. No. EP 14 15 3609.4 dated Jul. 14, 2017.
  • Australian Examination Report No. 1 corresponding to counterpart Australian Appln. No. AU 2013234418 dated Jul. 14, 2017.
  • Extended European Search Report corresponding to counterpart European Appln. No. EP 14 15 3610.2 dated Jul. 17, 2017.
  • Australian Examination Report No. 1 corresponding to counterpart Australian Appln. No. AU 2014200109 dated Jul. 20, 2017.
  • Australian Examination Report No. 1 corresponding to counterpart Australian Appln. No. AU 2014200074 dated Jul. 20, 2017.
  • Japanese Office Action corresponding to counterpart Japanese Appln. No. JP 2013-250857 dated Aug. 17, 2017.
  • Japanese Office Action corresponding to counterpart Japanese Appln. No. JP 2013-229471 dated Aug. 17, 2017.
  • Australian Examination Report No. 1 corresponding to counterpart Australian Appln. No. AU 2014200793 dated Sep. 2, 2017.
  • Extended European Search Report corresponding to counterpart European Appln. No. EP 17 17 8528.0 dated Oct. 13, 2017.
  • Australian Examination Report No. 1 corresponding to counterpart Australian Appln. No. AU 2013234420 dated Oct. 24, 2017.
  • Japanese Office Action corresponding to counterpart Japanese Appln. No. JP 2013-175379 dated Oct. 20, 2017.
  • Japanese Office Action corresponding to counterpart Japanese Appln. No. JP 2013-147701 dated Oct. 27, 2017.
  • Extended European Search Report corresponding to counterpart European Appln. No. EP 17 17 5656.2 dated Nov. 7, 2017.
  • Japanese Office Action corresponding to counterpart Japanese Appln. No. JP 2014-009738 dated Nov. 14, 2017.
  • European Office Action corresponding to counterpart European Appln. No. EP 13 17 3986.4 dated Nov. 29, 2017.
  • Japanese Office Action corresponding to counterpart Japanese Appln. No. JP 2017-075975 dated Dec. 4, 2017.
  • European Office Action corresponding to counterpart European Appln. No. EP 13 19 79585 dated Dec. 11, 2017.
  • Australian Examination Report No. 1 corresponding to counterpart Int'l Appln. No. AU 2013266989 dated Jul. 10, 2017.
  • Canadian Office Action dated Jun. 13, 2019 corresponding to counterpart Patent Application CA 2,821,619.
Patent History
Patent number: 11229434
Type: Grant
Filed: Jun 11, 2019
Date of Patent: Jan 25, 2022
Patent Publication Number: 20190290275
Assignee: COVIDIEN LP (Mansfield, MA)
Inventors: Sally Carter (Nashua, CT), Gerald Hodgkinson (Killingworth, CT), Richard Stevenson (Colchester, CT), Arthur Hislop (Plantsville, CT), Ernest Aranyi (Easton, CT), Jennifer (Whiffen) Diederich (Eagle River, AK)
Primary Examiner: Stephen F. Gerrity
Assistant Examiner: Joshua G Kotis
Application Number: 16/437,045
Classifications
Current U.S. Class: Methods (128/898)
International Classification: A61B 17/072 (20060101); A61B 17/068 (20060101); A61B 17/115 (20060101); A61B 17/10 (20060101); A61B 17/00 (20060101);